{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":321,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":321,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"35fb7377424e","filters":{"venue":"HemaSphere"}},"results":[{"id":"W4308963956","doi":"10.1097/hs9.0000000000000801","title":"Acalabrutinib Versus Investigator’s Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Saint John Regional Hospital; University of New Brunswick","funders":"Janssen Biotech; Novo Nordisk; Ascentage Pharma; Servier; Moderna; Celltrion; Incyte; Pharmacyclics; MEI Pharma; Karyopharm Therapeutics; Gilead Sciences; BeiGene; Sanofi; Cilag; TG Therapeutics; Pfizer; MorphoSys; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Internal medicine; Bendamustine; Chronic lymphocytic leukemia; Tolerability; Ofatumumab; Gastroenterology; Adverse effect; Oncology; Leukemia","authors":[{"name":"Paolo Ghia","is_ca":false},{"name":"Andrzej Pluta","is_ca":false},{"name":"Małgorzata Wach","is_ca":false},{"name":"Daniel Lysák","is_ca":false},{"name":"Martin Šimkovič","is_ca":false},{"name":"Iryna Kriachok","is_ca":false},{"name":"Árpád Illés","is_ca":false},{"name":"Javier de la Serna","is_ca":false},{"name":"Sean Dolan","is_ca":true},{"name":"Philip Campbell","is_ca":false},{"name":"Gerardo Musuraca","is_ca":false},{"name":"Abraham Jacob","is_ca":false},{"name":"Eric J. Avery","is_ca":false},{"name":"Jae Hoon Lee","is_ca":false},{"name":"Ganna Usenko","is_ca":false},{"name":"Min Hui Wang","is_ca":false},{"name":"Ting Yu","is_ca":false},{"name":"Wojciech Jurczak","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07152014511977556,"gpt":0.3352977625918449,"spread":0.2637776174720693,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001304056,0.0004750407,0.0008210692,0.0002462314,0.000341912,0.00004568945,0.0005999194,0.000355101,0.003473011],"category_scores_gemma":[0.004126677,0.0004869902,0.0002724574,0.00130898,0.000347533,0.0001473285,0.000677428,0.002007885,0.0004633766],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.265405,"about_ca_system_score_gemma":0.1279601,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004689221,"about_ca_topic_score_gemma":0.0008877887,"domain_scores_codex":[0.9941876,0.0004577825,0.001101328,0.001135978,0.001818767,0.001298531],"domain_scores_gemma":[0.9961385,0.001344746,0.0002868712,0.001346135,0.0001044352,0.0007792762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6186721,0.001320362,0.0004312495,0.001683952,0.0006555413,0.009717964,0.002310622,0.015763,0.003527805,0.001044155,0.3273049,0.01756841],"study_design_scores_gemma":[0.7278039,0.005290357,0.0003312984,0.0002407996,0.0001244293,0.00028828,0.0004834612,0.02065491,0.0009699707,0.00005847884,0.2432011,0.0005530145],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.971468,0.003054276,0.000002061138,0.0006219083,0.001655117,0.001740929,0.00005344927,0.0002327786,0.02117149],"genre_scores_gemma":[0.9826602,0.0001178496,0.0002033387,0.0005881799,0.001512242,0.0005201862,0.000189965,0.0001327582,0.01407531],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1374449,"threshold_uncertainty_score":0.9997582,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2974616558","doi":"10.1097/hs9.0000000000000286","title":"Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report","year":2019,"lang":"en","type":"review","venue":"HemaSphere","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Intensive care medicine; Normality; Pathological; Disease; Systematic review; MEDLINE; Pathology; Psychiatry","authors":[{"name":"Francesco Rodeghiero","is_ca":false},{"name":"Ingrid Pabinger","is_ca":false},{"name":"Margaret V. Ragni","is_ca":false},{"name":"Rezan A. Kadir","is_ca":false},{"name":"Erik Berntorp","is_ca":false},{"name":"Victor S. Blanchette","is_ca":true},{"name":"Imre Bodó","is_ca":false},{"name":"Alessandro Casini","is_ca":false},{"name":"Paolo Gresele","is_ca":false},{"name":"Riitta Lassila","is_ca":false},{"name":"Frank W.G. Leebeek","is_ca":false},{"name":"David Lillicrap","is_ca":true},{"name":"Diego Mezzano","is_ca":false},{"name":"Patrizia Noris","is_ca":false},{"name":"Alok Srivastava","is_ca":false},{"name":"Alberto Tosetto","is_ca":true},{"name":"Jerzy Windyga","is_ca":false},{"name":"Barbara Zieger","is_ca":false},{"name":"Nigel S. Key","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1192130332945532,"gpt":0.3737422878019674,"spread":0.2545292545074142,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000252674,0.0006569284,0.003792031,0.0001172102,0.0001206635,0.0000988349,0.0001031832,0.0003734424,0.00002038152],"category_scores_gemma":[0.000103681,0.0004798411,0.0003874602,0.000233736,0.00003981264,0.00006001983,0.00006506321,0.0002044112,0.00003594251],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001436792,"about_ca_system_score_gemma":0.0002101893,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003582737,"about_ca_topic_score_gemma":0.00001453039,"domain_scores_codex":[0.9973076,0.00008761289,0.0009782211,0.0008977341,0.0002690427,0.0004597799],"domain_scores_gemma":[0.9982951,0.0001618705,0.0004741997,0.0006717019,0.00007840767,0.0003187179],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001297241,0.0008418682,0.00003046524,0.9520131,0.002005992,0.0003818612,0.0002866627,0.000004253865,0.000002023679,0.0001273754,0.00154605,0.0426306],"study_design_scores_gemma":[0.00799671,0.001989571,0.00001133765,0.4771262,0.0185144,0.0148998,0.002409475,0.002597659,0.000002690576,0.0002861359,0.4717838,0.002382234],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001142817,0.9813313,0.0002720382,0.0000404103,0.0001244036,0.01385756,0.0001145345,0.00009924636,0.003017699],"genre_scores_gemma":[0.001012247,0.9788968,0.009018668,0.0001539693,0.0001029476,0.003205887,0.001310766,0.0002623503,0.006036377],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4748869,"threshold_uncertainty_score":0.9997653,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3129688332","doi":"10.1097/hs9.0000000000000540","title":"Hemophilia Gene Therapy: Approaching the First Licensed Product","year":2021,"lang":"en","type":"review","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"Genetic enhancement; Clinical trial; Medicine; Intensive care medicine; Gene; Biology; Internal medicine; Genetics","authors":[{"name":"Paul Batty","is_ca":true},{"name":"David Lillicrap","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1062999990702083,"gpt":0.3599660407400558,"spread":0.2536660416698476,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009472823,0.0007643558,0.002571307,0.00008671641,0.0003304704,0.0001211213,0.0005749675,0.0003990018,0.01035845],"category_scores_gemma":[0.0001942861,0.0004443974,0.001315646,0.001013684,0.0001791452,0.00005059218,0.0002571624,0.001872211,0.0003504827],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003055897,"about_ca_system_score_gemma":0.001099564,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004752467,"about_ca_topic_score_gemma":0.00001993599,"domain_scores_codex":[0.9960365,0.000398776,0.0007386049,0.001122821,0.0009452215,0.0007581087],"domain_scores_gemma":[0.9964345,0.0003662026,0.0002726293,0.00250444,0.0001992978,0.0002229668],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003952143,0.0002115728,0.000007356583,0.0115737,0.0008436888,0.0002358293,0.0002403328,5.185724e-7,0.00004768317,0.00006742776,0.01001799,0.9767144],"study_design_scores_gemma":[0.0006228209,0.00009974595,0.000004135245,0.007547821,0.0004699755,0.00112416,0.00006388997,0.000006619191,0.0001370675,0.000005698907,0.9895067,0.0004113487],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003363579,0.9796646,0.00001099208,0.001133961,0.0003335927,0.003761744,0.00001590215,0.0001407485,0.01490486],"genre_scores_gemma":[0.000005033183,0.9420991,0.0004634087,0.0004331356,0.002365611,0.0005421371,0.0002310747,0.000280296,0.05358023],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9794887,"threshold_uncertainty_score":0.9998008,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4400982166","doi":"10.1002/hem3.136","title":"Long‐term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM‐3 study","year":2024,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Pfizer","keywords":"Multiple myeloma; Term (time); Refractory (planetary science); Medicine; Oncology; Internal medicine; Biology; Physics","authors":[{"name":"Michael H. Tomasson","is_ca":false},{"name":"Shinsuke Iida","is_ca":false},{"name":"Rubén Niesvizky","is_ca":false},{"name":"Mohamad Mohty","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Joaquín Martínez‐López","is_ca":false},{"name":"Guenther Koehne","is_ca":false},{"name":"Paula Rodríguez‐Otero","is_ca":false},{"name":"H. Miles Prince","is_ca":false},{"name":"Andrea Viqueira","is_ca":false},{"name":"Eric Leip","is_ca":false},{"name":"Umberto Conte","is_ca":false},{"name":"Sharon T. Sullivan","is_ca":false},{"name":"Alexander M. Lesokhin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01670397617652239,"gpt":0.2747062140453024,"spread":0.25800223786878,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001878861,0.0002129011,0.0003832835,0.00004925918,0.00006320614,0.00003125143,0.0001142438,0.00007267409,0.0008802231],"category_scores_gemma":[0.0001383242,0.0001104539,0.00004297855,0.0002763825,0.0001103016,0.0001226885,0.00009910022,0.0003087869,0.00003395366],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008090527,"about_ca_system_score_gemma":0.000130266,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008295779,"about_ca_topic_score_gemma":0.004976191,"domain_scores_codex":[0.998279,0.0001507935,0.0003200021,0.000417925,0.0005429782,0.0002893551],"domain_scores_gemma":[0.9987563,0.0005034528,0.00005223965,0.0004731632,0.00007299529,0.0001417898],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008178839,0.001102218,0.9503298,0.0001327063,0.0003448249,0.0007379151,0.0006298283,6.307095e-7,0.000032386,0.000007313004,0.0001734928,0.03833004],"study_design_scores_gemma":[0.01704211,0.001695228,0.9794263,0.0004354835,0.0001176449,0.000004011418,0.0006397177,0.00007843113,0.0000530675,0.000006279993,0.0003865188,0.0001151637],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958485,0.001741197,0.00001468882,0.0001911765,0.00009945828,0.001514302,0.000180945,0.00004132011,0.0003683502],"genre_scores_gemma":[0.9986615,0.0001482683,0.0002462189,0.00002378851,0.00004493874,0.00004667881,0.0001935217,0.00004016571,0.0005949115],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03821488,"threshold_uncertainty_score":0.9637826,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4379467996","doi":"10.1097/hs9.0000000000000900","title":"Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Antithrombotic; Hemostasis; Thrombosis; Atrial fibrillation; Clotting factor; Stroke (engine); Venous thrombosis; Intensive care medicine; Internal medicine; Physical therapy","authors":[{"name":"Roger E. G. Schutgens","is_ca":false},{"name":"Víctor Jiménez‐Yuste","is_ca":false},{"name":"Miguel A. Escobar","is_ca":false},{"name":"Anna Falanga","is_ca":false},{"name":"Bruna Gigante","is_ca":false},{"name":"Robert Klamroth","is_ca":false},{"name":"Riitta Lassila","is_ca":false},{"name":"Frank W.G. Leebeek","is_ca":false},{"name":"Michael Makris","is_ca":false},{"name":"Tarek Owaidah","is_ca":false},{"name":"Michelle Sholzberg","is_ca":true},{"name":"Andreas Tiede","is_ca":false},{"name":"David J. Werring","is_ca":false},{"name":"H. Bart van der Worp","is_ca":false},{"name":"Jerzy Windyga","is_ca":false},{"name":"Giancarlo Castaman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05393970505194876,"gpt":0.3947387255850169,"spread":0.3407990205330681,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004679924,0.0002885292,0.0005931554,0.0001099824,0.0001071413,0.00003236831,0.0001234663,0.000187651,0.000323067],"category_scores_gemma":[0.0003540431,0.0001904717,0.0001123241,0.0008526591,0.0001601191,0.0002733598,0.00005382717,0.0003006779,0.0009078376],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002547764,"about_ca_system_score_gemma":0.0003253563,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001322141,"about_ca_topic_score_gemma":0.0001228538,"domain_scores_codex":[0.9973648,0.0001973916,0.000510504,0.0006462106,0.0006769215,0.0006041396],"domain_scores_gemma":[0.9982697,0.000303512,0.0001044012,0.0007278404,0.000225826,0.0003686896],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001041328,0.004207787,0.9768451,0.00009170701,0.0001777908,0.001347213,0.0002376004,0.00001739438,0.00002353042,0.000081814,0.002022596,0.01390609],"study_design_scores_gemma":[0.009575013,0.006587997,0.9705141,0.0002459326,0.0001548327,0.00002511214,0.0004158825,0.0002762858,0.0001382553,0.00003583643,0.01179139,0.000239333],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886076,0.0002491308,0.000004614409,0.002438021,0.0001416177,0.0011846,0.00001114218,0.0001830997,0.007180144],"genre_scores_gemma":[0.9856065,0.0003270403,0.003472311,0.0002682224,0.0002447848,0.00008822687,0.0001947905,0.00007283816,0.009725288],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01366676,"threshold_uncertainty_score":0.9998701,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2926447864","doi":"10.1097/hs9.0000000000000185","title":"CAR‐T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and Hope","year":2019,"lang":"en","type":"review","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Sanofi Genzyme; Therakos; Celgene; Mallinckrodt Pharmaceuticals; Gilead Sciences; Sanofi; AOP Orphan; GlaxoSmithKline; Amgen","keywords":"Medicine; Chimeric antigen receptor; Cytokine release syndrome; Lymphoma; Hematopoietic stem cell transplantation; Cell therapy; Clinical trial; Oncology; Transplantation; Immunotherapy; Adverse effect; Blinatumomab; Immunology; Internal medicine; Stem cell; CD19; Antigen; Immune system; Biology","authors":[{"name":"Georg Hopfinger","is_ca":false},{"name":"Ulrich Jäger","is_ca":false},{"name":"Nina Worel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05290399143292113,"gpt":0.3387629218292847,"spread":0.2858589303963636,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000485214,0.0007386809,0.002785241,0.0002196701,0.00005583873,0.00006497814,0.0003341393,0.0007603567,0.004419697],"category_scores_gemma":[0.00002753116,0.0005622981,0.0005514665,0.000595851,0.00008648803,0.00006733076,0.0002115886,0.0007973171,0.0007972291],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003497485,"about_ca_system_score_gemma":0.0008195252,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001267159,"about_ca_topic_score_gemma":0.00005014732,"domain_scores_codex":[0.9966037,0.0002914631,0.0006800541,0.0009294572,0.0006045221,0.0008907802],"domain_scores_gemma":[0.9977859,0.0003353217,0.0002221617,0.00124776,0.00008548494,0.0003233284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001364988,0.002843291,0.0001772684,0.03250128,0.0001085956,0.0003886057,0.0002204764,2.74767e-8,0.0001436653,0.00001615421,0.003465016,0.9599991],"study_design_scores_gemma":[0.01486296,0.0003916089,0.00002557644,0.004309459,0.0002189882,0.0001189843,0.00009912381,0.000006337422,0.0001015504,0.000007388263,0.9793566,0.0005014124],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003569343,0.9563654,0.000001611371,0.00003131483,0.0002104709,0.002761345,0.0000515645,0.00006391559,0.03694502],"genre_scores_gemma":[0.000256026,0.902877,0.00007557411,0.0001595306,0.0002933303,0.0001531229,0.000132736,0.0002483013,0.09580443],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9758916,"threshold_uncertainty_score":0.9999807,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2949444368","doi":"10.1097/01.hs9.0000561592.51072.9b","title":"S828 A RANDOMIZED, DOUBLE BLIND PHASE 2 STUDY OF 3 DIFFERENT DOSES OF PRM‐151 IN PATIENTS WITH MYELOFIBROSIS WHO WERE PREVIOUSLY TREATED WITH OR INELIGIBLE FOR RUXOLITINIB","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Medicine; Ruxolitinib; Essential thrombocythemia; Internal medicine; Randomization; Bone marrow; Polycythemia vera; Gastroenterology; Randomized controlled trial; Anemia","authors":[{"name":"Srđan Verstovšek","is_ca":false},{"name":"Moshe Talpaz","is_ca":false},{"name":"Martha Wadleigh","is_ca":false},{"name":"Jodie Palmer","is_ca":false},{"name":"Alessandro Isidori","is_ca":false},{"name":"Peter A.W. te Boekhorst","is_ca":false},{"name":"Michael R. Savona","is_ca":false},{"name":"Jason Gotlib","is_ca":false},{"name":"Robert P. Hasserjian","is_ca":false},{"name":"Olga Pozdnyakova","is_ca":false},{"name":"Olga K. Weinberg","is_ca":false},{"name":"Thorsten Derlin","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Ellen K. Ritchie","is_ca":false},{"name":"Joana Mascarenhas","is_ca":false},{"name":"Ruben A. Mesa","is_ca":false},{"name":"Bernt van den Blink","is_ca":false},{"name":"Claire Harrison","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03123546288346078,"gpt":0.3296657506900283,"spread":0.2984302878065675,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003262399,0.0003480242,0.001875941,0.0001830472,0.00002938079,0.00001823844,0.0001620446,0.0001093708,0.002144212],"category_scores_gemma":[0.00005312975,0.0001887545,0.0001489089,0.000515019,0.0001296993,0.0000983771,0.00005395352,0.0001900488,0.000004367864],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009242212,"about_ca_system_score_gemma":0.0001928899,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000461836,"about_ca_topic_score_gemma":0.0004234751,"domain_scores_codex":[0.997447,0.0001348613,0.0007398194,0.0004780975,0.0007359572,0.0004642553],"domain_scores_gemma":[0.9980065,0.0003744833,0.0003316171,0.0006615399,0.0004655835,0.0001603048],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6907316,0.007296328,0.2959671,0.00126226,0.0004859821,0.000006857167,0.001557955,0.00001096551,0.001171189,0.00001568151,0.00008123071,0.001412789],"study_design_scores_gemma":[0.9385372,0.0264626,0.008935053,0.001801359,0.0004030833,0.000003967467,0.001877579,0.0001134745,0.02150937,0.000008870486,0.00009706875,0.0002503114],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9818859,0.0001348473,0.00001212474,0.00002900996,0.00001924775,0.0164554,0.00003337286,0.0000291751,0.00140094],"genre_scores_gemma":[0.9888384,0.00004120067,0.0001658864,0.00001355525,0.00002839925,0.00089735,0.00008452416,0.00008081189,0.009849867],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.287032,"threshold_uncertainty_score":0.998768,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3005061455","doi":"10.1097/hs9.0000000000000327","title":"Modifiable Lifestyle and Medical Risk Factors Associated With Myeloproliferative Neoplasms","year":2020,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Cancer Council Western Australia; National Health and Medical Research Council; Queen's University; Queen's University Belfast; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Odds ratio; Confidence interval; Internal medicine; Population; Cohort study; Cohort; Essential thrombocythemia; Demography; Pediatrics; Polycythemia vera; Environmental health","authors":[{"name":"Andrew Duncombe","is_ca":false},{"name":"Lesley Anderson","is_ca":false},{"name":"Glen James","is_ca":false},{"name":"Frank de Vocht","is_ca":false},{"name":"Lin Fritschi","is_ca":false},{"name":"Ruben A. Mesa","is_ca":false},{"name":"Mike Clarke","is_ca":false},{"name":"Mary Frances McMullin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02583528276933299,"gpt":0.2479246808615806,"spread":0.2220893980922476,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001311578,0.0003684813,0.0006686024,0.00002574427,0.0002168968,0.00004808152,0.00007361449,0.0002255631,0.001715865],"category_scores_gemma":[0.0009929698,0.000238503,0.000081838,0.0002865129,0.0001489096,0.0001136251,0.0000622478,0.000452925,0.00005641703],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007784728,"about_ca_system_score_gemma":0.0002991214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001193458,"about_ca_topic_score_gemma":0.0001383749,"domain_scores_codex":[0.9979194,0.0001159395,0.0003055304,0.0005621406,0.0007036079,0.0003933604],"domain_scores_gemma":[0.9981973,0.0003987084,0.0001486422,0.0001894177,0.0001519833,0.0009139773],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002949823,0.0004900783,0.98952,0.00006743048,0.0008518469,0.0003209792,0.002428131,0.00007051335,0.00005120729,0.0007856766,0.004202378,0.000916734],"study_design_scores_gemma":[0.0340329,0.0133659,0.8469813,0.001947358,0.00242625,0.0002612629,0.005737524,0.04269196,0.03520135,0.0004038906,0.01475305,0.002197252],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903975,0.0006282151,0.0001612713,0.004288035,0.00004063531,0.0006677681,0.00006309194,0.000168711,0.003584782],"genre_scores_gemma":[0.9967194,0.0003443162,0.000533636,0.001534514,0.0001387411,0.00009515329,0.000102561,0.00005247046,0.0004792041],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1425387,"threshold_uncertainty_score":0.9991967,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2802748326","doi":"10.1097/hs9.0000000000000044","title":"Clinical Utility of Next‐generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single‐Center Experience","year":2018,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"European Hematology Association; Bristol-Myers Squibb","keywords":"Medicine; Myeloid; Oncology; Internal medicine; Myelofibrosis; DNA sequencing; Bioinformatics; Gene; Biology; Genetics; Bone marrow","authors":[{"name":"Waleed Alduaij","is_ca":true},{"name":"Caroline McNamara","is_ca":true},{"name":"Andre C. Schuh","is_ca":true},{"name":"Andrea Arruda","is_ca":true},{"name":"Mahadeo A. Sukhai","is_ca":true},{"name":"Nisha Kanwar","is_ca":true},{"name":"Mariam Thomas","is_ca":true},{"name":"Jay Y. Spiegel","is_ca":true},{"name":"Theodore A. Kennedy","is_ca":true},{"name":"Tracy Stockley","is_ca":true},{"name":"Hubert Tsui","is_ca":true},{"name":"Rebecca Devlin","is_ca":true},{"name":"Hassan Sibai","is_ca":true},{"name":"Dawn Maze","is_ca":true},{"name":"Aaron D. Schimmer","is_ca":true},{"name":"Karen Yee","is_ca":true},{"name":"Steven M. Chan","is_ca":true},{"name":"Suzanne Kamel‐Reid","is_ca":true},{"name":"Vikas Gupta","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1708202741207578,"gpt":0.3693284758710335,"spread":0.1985082017502757,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004500155,0.0001842724,0.0004453806,0.00003523217,0.00006347735,0.00001561151,0.0001210196,0.00009227573,0.0004983235],"category_scores_gemma":[0.00006064619,0.000119142,0.0001281631,0.0002817402,0.0003022961,0.0001145711,0.00005434318,0.0001370921,0.00001451772],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009266441,"about_ca_system_score_gemma":0.0001000184,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006277396,"about_ca_topic_score_gemma":0.000291673,"domain_scores_codex":[0.998073,0.0001853024,0.0007632547,0.0003716652,0.0003886321,0.000218129],"domain_scores_gemma":[0.9989189,0.0001235872,0.0002144196,0.0004565247,0.0002219721,0.00006460037],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008228398,0.00334494,0.9203704,0.0005350121,0.0005015865,0.000175076,0.02485688,0.000007659661,0.006947116,0.006017476,0.001470758,0.03495025],"study_design_scores_gemma":[0.01391379,0.007632261,0.5448128,0.003388029,0.0005682504,0.0002552792,0.04576325,0.01311623,0.364021,0.0006660181,0.005114896,0.0007481998],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878242,0.0002688657,0.0002890946,0.0003054495,0.0001445694,0.0008386332,0.000007928315,0.00001243098,0.01030881],"genre_scores_gemma":[0.9929632,0.0001710355,0.006033311,0.0004037922,0.0001634138,0.0001339718,0.00001719484,0.0000119316,0.0001021488],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3755576,"threshold_uncertainty_score":0.5456293,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283217918","doi":"10.1097/hs9.0000000000000745","title":"A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL)","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Follicular lymphoma; Internal medicine; Refractory (planetary science); Retrospective cohort study; Rituximab; Confidence interval; Cohort; Oncology; Lymphoma; Surgery; Biology","authors":[{"name":"Gilles Salles","is_ca":false},{"name":"Stephen J. Schuster","is_ca":false},{"name":"Luca Fischer","is_ca":false},{"name":"John Kuruvilla","is_ca":true},{"name":"Piers Patten","is_ca":false},{"name":"Bastian von Tresckow","is_ca":false},{"name":"Sonali M. Smith","is_ca":false},{"name":"Ana Jiménez Ubieto","is_ca":false},{"name":"Keith L. Davis","is_ca":false},{"name":"Saurabh Nagar","is_ca":false},{"name":"Jie Zhang","is_ca":false},{"name":"Vamsi Bollu","is_ca":false},{"name":"Etienne Jousseaume","is_ca":false},{"name":"Roberto Ramos","is_ca":false},{"name":"Yucai Wang","is_ca":false},{"name":"Brian K. Link","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009417120956188822,"gpt":0.2423178814031822,"spread":0.2329007604469934,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006130889,0.000285222,0.0009850217,0.00006362046,0.0001123764,0.000004041151,0.00008629222,0.00004735844,0.0009556158],"category_scores_gemma":[0.0000490241,0.0001704084,0.0001778981,0.0003074039,0.00004251523,0.00004740678,0.00006993016,0.00005338861,0.00000552991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001724105,"about_ca_system_score_gemma":0.000251923,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002483975,"about_ca_topic_score_gemma":0.0005286744,"domain_scores_codex":[0.9980478,0.00009174798,0.0004672664,0.0004426612,0.0007311104,0.0002193936],"domain_scores_gemma":[0.9985173,0.00007516349,0.000371709,0.0006537423,0.0002742032,0.0001078397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002139188,0.0259385,0.9642947,0.00003673375,0.002298992,0.0001915524,0.001255793,0.000008883231,0.000009725144,0.00003850408,0.0002835366,0.003503896],"study_design_scores_gemma":[0.03008018,0.03214686,0.9329118,0.00004974055,0.001004199,0.000009203765,0.002839899,0.000007876529,0.000285512,0.000005636348,0.0005060036,0.0001531531],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958943,0.00009467978,8.661727e-7,0.00003893918,0.0001029254,0.002520008,0.00008910675,0.00003853008,0.001220707],"genre_scores_gemma":[0.9973127,0.00003500453,0.0002608695,0.00006093648,0.00001322688,0.0009051147,0.00006449624,0.00004260619,0.00130501],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03138295,"threshold_uncertainty_score":0.9999576,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3193211635","doi":"10.1097/hs9.0000000000000617","title":"Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial","year":2021,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Cytarabine; Hazard ratio; Clinical endpoint; Myeloid leukemia; Randomized controlled trial; Surgery; Confidence interval","authors":[{"name":"Hartmut Döhner","is_ca":false},{"name":"Argiris Symeonidis","is_ca":false},{"name":"Dries Deeren","is_ca":false},{"name":"Judit Demeter","is_ca":false},{"name":"Miguel Á. Sanz","is_ca":false},{"name":"Αchilles Anagnostopoulos","is_ca":false},{"name":"Jordi Esteve","is_ca":false},{"name":"Walter Fiedler","is_ca":false},{"name":"Kimmo Porkka","is_ca":false},{"name":"Hee‐Je Kim","is_ca":false},{"name":"Je‐Hwan Lee","is_ca":false},{"name":"Kensuke Usuki","is_ca":false},{"name":"Stefano D’Ardìa","is_ca":false},{"name":"Chul Won Jung","is_ca":false},{"name":"Olga Salamero","is_ca":false},{"name":"Heinz‐August Horst","is_ca":false},{"name":"Christian Récher","is_ca":false},{"name":"Philippe Rousselot","is_ca":false},{"name":"Irwindeep Sandhu","is_ca":true},{"name":"Koen Theunissen","is_ca":false},{"name":"Felicitas Thol","is_ca":false},{"name":"Konstanze Döhner","is_ca":false},{"name":"Veronica Teleanu","is_ca":false},{"name":"Daniel J. DeAngelo","is_ca":false},{"name":"Tomoki Naoe","is_ca":false},{"name":"Mikkael A. Sekeres","is_ca":false},{"name":"Valérie Belsack","is_ca":false},{"name":"Miaomiao Ge","is_ca":false},{"name":"Tillmann Taube","is_ca":false},{"name":"Oliver G. Ottmann","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02104062024741899,"gpt":0.311902993568538,"spread":0.290862373321119,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006598194,0.0003353906,0.001157341,0.0001312592,0.0001127038,0.00005226259,0.0001151499,0.0002451452,0.0005627338],"category_scores_gemma":[0.0005817205,0.0002414976,0.0002627902,0.0006457682,0.0001533015,0.0002477872,0.00005564446,0.0005549182,0.00002460458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001390346,"about_ca_system_score_gemma":0.002798938,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001075494,"about_ca_topic_score_gemma":0.00005654989,"domain_scores_codex":[0.9972998,0.0002289218,0.0005563372,0.000643779,0.0006963203,0.0005748681],"domain_scores_gemma":[0.9979571,0.0003333496,0.0001705011,0.0005000932,0.0008518362,0.0001871112],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9694588,0.0006611184,0.0004932379,0.00006921266,0.0007155361,0.0001146471,0.0004121431,0.00001149566,0.002886469,0.00005815547,0.004574042,0.02054521],"study_design_scores_gemma":[0.9175329,0.003827112,0.0003376287,0.0001617577,0.0002410032,0.00002026852,0.0003065181,0.0001916493,0.07067008,0.0001106727,0.006333383,0.0002669955],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905725,0.0003791067,0.001301661,0.0007154737,0.0002911563,0.005735622,0.0001361291,0.00007493111,0.0007934178],"genre_scores_gemma":[0.9873887,0.0003519533,0.004186712,0.0007193239,0.0004605745,0.001581814,0.0009647942,0.0001391929,0.004206993],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06778361,"threshold_uncertainty_score":0.9847988,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2903296906","doi":"10.1097/hs9.0000000000000159","title":"Maintenance Therapy With Interleukin‐2 for Childhood AML","year":2018,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Assistance publique-Hôpitaux de Paris; Institut National Du Cancer; Fondation ARC pour la Recherche sur le Cancer; CNIB; Société Française de lutte contre les Cancers et les leucémies de l'Enfant et de l'Adolescent; Association Laurette Fugain","keywords":"Medicine; Cytarabine; Internal medicine; Mitoxantrone; Maintenance therapy; Acute myeloblastic leukemia; Population; Randomized controlled trial; Leukemia; Chemotherapy; Surgery; Oncology","authors":[{"name":"Arnaud Petit","is_ca":false},{"name":"Stéphane Ducassou","is_ca":false},{"name":"Thierry Leblanc","is_ca":false},{"name":"Marlène Pasquet","is_ca":false},{"name":"Alexandra Rousseau","is_ca":false},{"name":"Christine Ragu","is_ca":false},{"name":"Marine Cachanado","is_ca":false},{"name":"Brigitte Nelken","is_ca":false},{"name":"Yves Bertrand","is_ca":false},{"name":"Gérard Michel","is_ca":false},{"name":"Virginie Gandemer","is_ca":false},{"name":"Wendy Cuccuini","is_ca":false},{"name":"Odile Fenneteau","is_ca":false},{"name":"Hélène Lapillonne","is_ca":false},{"name":"Anne Auvrignon","is_ca":false},{"name":"André Baruchel","is_ca":false},{"name":"Guy Leverger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01942172437078197,"gpt":0.2944160902014198,"spread":0.2749943658306378,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001528868,0.0001762479,0.0002707861,0.00003624249,0.00009943518,0.00002297457,0.0001659066,0.00009096072,0.0009859445],"category_scores_gemma":[0.00008027049,0.0001127814,0.00008423054,0.0002090087,0.0002384153,0.00007243425,0.00003819252,0.0002155049,0.0002455504],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001580953,"about_ca_system_score_gemma":0.0003842227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002539812,"about_ca_topic_score_gemma":0.00003443235,"domain_scores_codex":[0.9987662,0.00001763672,0.0001618273,0.0003462934,0.0002345625,0.0004734673],"domain_scores_gemma":[0.9989161,0.00006429962,0.00005202929,0.0004799944,0.0003222191,0.0001653616],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01186151,0.001234255,0.01566226,0.0004737468,0.001019533,0.000282532,0.004884251,0.000001709473,0.01955032,0.004850725,0.6592826,0.2808965],"study_design_scores_gemma":[0.02119614,0.01022595,0.02894916,0.0008172078,0.00006681666,0.000786183,0.00152576,0.0005430922,0.07664502,0.0007770162,0.8579211,0.0005465139],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9227957,0.0009874717,0.008773375,0.006055968,0.0001790909,0.002358342,0.00002116587,0.0002671694,0.05856173],"genre_scores_gemma":[0.9596288,0.0001185372,0.01625428,0.002176793,0.0009573476,0.0001814973,0.00001733927,0.00008552345,0.02057984],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.28035,"threshold_uncertainty_score":0.9999273,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3157098966","doi":"10.1097/hs9.0000000000000562","title":"Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes from the Phase II JAKARTA2 Trial","year":2021,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Sierra Oncology; Incyte; Gilead Sciences; CTI Biopharma; Celgene; Sanofi; Bristol-Myers Squibb","keywords":"Myelofibrosis; Ruxolitinib; Medicine; Quality of life (healthcare); Internal medicine; Clinical trial; Population; Physical therapy; Bone marrow","authors":[{"name":"Claire Harrison","is_ca":false},{"name":"Nicolaas Schaap","is_ca":false},{"name":"Alessandro M. Vannucchi","is_ca":false},{"name":"Jean‐Jacques Kiladjian","is_ca":false},{"name":"Éric Jourdan","is_ca":false},{"name":"Richard T. Silver","is_ca":false},{"name":"Harry C. Schouten","is_ca":false},{"name":"Francesco Passamonti","is_ca":false},{"name":"Sonja Zweegman","is_ca":false},{"name":"Moshe Talpaz","is_ca":false},{"name":"Srđan Verstovšek","is_ca":false},{"name":"Derek Tang","is_ca":false},{"name":"Pranav Abraham","is_ca":false},{"name":"Jennifer Lord‐Bessen","is_ca":false},{"name":"Shelonitda Rose","is_ca":false},{"name":"Shien Guo","is_ca":false},{"name":"Weiqin Liao","is_ca":false},{"name":"Ruben A. Mesa","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02729231896859579,"gpt":0.2889486548959623,"spread":0.2616563359273665,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003590806,0.000638513,0.001993223,0.00006525981,0.0003036508,0.00005729188,0.0001006419,0.0002555641,0.0004583766],"category_scores_gemma":[0.0004093006,0.0003630309,0.0002039715,0.0007001377,0.0002525997,0.0001816634,0.00009988011,0.0003805079,0.000004753018],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001671717,"about_ca_system_score_gemma":0.0007593193,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002913998,"about_ca_topic_score_gemma":0.001083407,"domain_scores_codex":[0.9949413,0.000512302,0.002187576,0.0009484076,0.0008076667,0.0006027814],"domain_scores_gemma":[0.9962962,0.0005898773,0.001336969,0.000848365,0.0004868973,0.0004417017],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02596561,0.006188149,0.9517774,0.0001454139,0.001781077,0.00004580447,0.002882026,0.000004674799,0.0001612053,0.0001213466,0.000183718,0.01074359],"study_design_scores_gemma":[0.1670061,0.01311946,0.8154988,0.0009466852,0.0004273381,0.00000851997,0.0008138987,0.00002301547,0.001721071,0.00002820985,0.00005522185,0.0003517219],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918093,0.001638971,0.000002777063,0.001860573,0.00008724246,0.003950311,0.0002235891,0.00009952437,0.0003276883],"genre_scores_gemma":[0.9969534,0.00008638597,0.0005362889,0.0005680089,0.00002656236,0.0004031449,0.001118796,0.00007964791,0.000227722],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1410404,"threshold_uncertainty_score":0.9998822,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4387969051","doi":"10.1097/hs9.0000000000000963","title":"Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 Trials","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Genentech; Italfarmaco; Galecto; Sierra Oncology; CTI Biopharma; Incyte; Jazz Pharmaceuticals; Yuhan; Gilead Sciences; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Constellation Pharmaceuticals","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Post-hoc analysis; Internal medicine; Population; Anemia; Gastroenterology; Bone marrow","authors":[{"name":"Jean‐Jacques Kiladjian","is_ca":false},{"name":"Alessandro M. Vannucchi","is_ca":false},{"name":"Aaron T. Gerds","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Srđan Verstovšek","is_ca":false},{"name":"Miklós Egyed","is_ca":false},{"name":"Uwe Platzbecker","is_ca":false},{"name":"Jiřı́ Mayer","is_ca":false},{"name":"Sebastian Grosicki","is_ca":false},{"name":"Árpád Illés","is_ca":false},{"name":"T Woźny","is_ca":false},{"name":"Stephen T. Oh","is_ca":false},{"name":"Donal P. McLornan","is_ca":false},{"name":"Ilya Kirgner","is_ca":false},{"name":"Sung‐Soo Yoon","is_ca":false},{"name":"Claire Harrison","is_ca":false},{"name":"Barbara Klencke","is_ca":false},{"name":"Mei Huang","is_ca":false},{"name":"Jun Kawashima","is_ca":false},{"name":"Ruben A. Mesa","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03576256372437367,"gpt":0.3265376126777602,"spread":0.2907750489533865,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008501992,0.0004129934,0.00340246,0.0003066516,0.0000991937,0.00006050703,0.0001104572,0.0001541345,0.004374188],"category_scores_gemma":[0.0006718982,0.0002538514,0.0006320605,0.001886474,0.0001015002,0.0001317576,0.00006163934,0.0001808323,0.0003527529],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001275022,"about_ca_system_score_gemma":0.0001340249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006554365,"about_ca_topic_score_gemma":0.002877685,"domain_scores_codex":[0.9969019,0.0003882057,0.0009870962,0.0006702258,0.0006209246,0.0004316251],"domain_scores_gemma":[0.9968536,0.001803565,0.0003360792,0.0005395802,0.0002418974,0.0002252749],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1745986,0.002654593,0.7989403,0.00006746411,0.009269914,0.0002596645,0.001006195,0.00009927675,0.0002291584,0.0001733476,0.001497769,0.01120367],"study_design_scores_gemma":[0.4908574,0.001313053,0.4989255,0.0002428748,0.005423375,0.000001002393,0.0002435303,0.0005965973,0.001642999,0.0001688166,0.0002542281,0.0003305492],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938114,0.0004649017,0.0001117662,0.001128019,0.00009038929,0.002861096,0.000409674,0.0001366333,0.0009860937],"genre_scores_gemma":[0.9945889,0.0002393175,0.001512526,0.0002673516,0.00009700863,0.0007717522,0.00215871,0.00005292337,0.0003115685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3162588,"threshold_uncertainty_score":0.9999914,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388738310","doi":"10.1097/01.hs9.0000936164.84357.ed","title":"P09 DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE (D-RD) VERSUS LENALIDOMIDE AND DEXAMETHASONE (RD) ALONE IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): UPDATED ANALYSIS OF THE PHASE 3 MAIA STUDY","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Lenalidomide; Medicine; Daratumumab; Internal medicine; Multiple myeloma; Clinical endpoint; Dexamethasone; Surgery; Phases of clinical research; Minimal residual disease; Progression-free survival; Oncology; Gastroenterology; Chemotherapy; Randomized controlled trial; Bone marrow","authors":[{"name":"Katja Weisel","is_ca":false},{"name":"Shaji Kumar","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"T. Facon","is_ca":false},{"name":"Torben Plesner","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false},{"name":"Supratik Basu","is_ca":false},{"name":"Hareth Nahi","is_ca":false},{"name":"Cyrille Hulin","is_ca":false},{"name":"Hang Quach","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Michael O’Dwyer","is_ca":false},{"name":"Aurore Perrot","is_ca":false},{"name":"Christopher P. Venner","is_ca":true},{"name":"Noopur Raje","is_ca":false},{"name":"Mourad Tiab","is_ca":false},{"name":"Margaret Macro","is_ca":false},{"name":"Laurent Frenzel","is_ca":false},{"name":"Xavier Leleu","is_ca":false},{"name":"Huiling Pei","is_ca":false},{"name":"Maria Krevvata","is_ca":false},{"name":"Robin Carson","is_ca":false},{"name":"F. Borgsten","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02799922324280263,"gpt":0.3080481877675247,"spread":0.2800489645247221,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005611796,0.0005459,0.001451804,0.0005686247,0.0002262008,0.00005996241,0.0002423202,0.0001749396,0.0002036701],"category_scores_gemma":[0.0004816755,0.0003662652,0.0001941734,0.003455868,0.0002914492,0.0002100421,0.0001666342,0.0004423615,0.00001445025],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001873896,"about_ca_system_score_gemma":0.0001936998,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003351879,"about_ca_topic_score_gemma":0.0136797,"domain_scores_codex":[0.9960263,0.0004183888,0.0007556024,0.0009146354,0.001046766,0.0008382613],"domain_scores_gemma":[0.9970499,0.001153912,0.0002618777,0.00085045,0.000227707,0.0004562094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03794546,0.002424846,0.9437218,0.0001778006,0.004412899,0.0009315512,0.002054717,0.0003600045,0.001303138,0.000004092806,0.0003660552,0.006297625],"study_design_scores_gemma":[0.1801837,0.001853013,0.8013242,0.000264258,0.00278524,0.00001190155,0.002291368,0.007571246,0.003234639,0.000007061163,0.0001023941,0.0003709447],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955875,0.0006758022,0.00006517743,0.0002725337,0.00007434004,0.002708817,0.0003834384,0.00009311862,0.0001393058],"genre_scores_gemma":[0.9976153,0.0002895649,0.0008342122,0.00004867183,0.00003023844,0.0002115549,0.0006370769,0.00007398318,0.0002593512],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1423975,"threshold_uncertainty_score":0.9998789,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4399045499","doi":"10.1002/hem3.74","title":"First‐line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age‐matched general population: A pooled post hoc analysis","year":2024,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Alberta Health Services","funders":"Pharmacyclics","keywords":"Ibrutinib; Post-hoc analysis; Chronic lymphocytic leukemia; Medicine; Oncology; Internal medicine; Post hoc; Pooled analysis; Survival analysis; Population; Leukemia; Meta-analysis","authors":[{"name":"Paolo Ghia","is_ca":false},{"name":"Carolyn Owen","is_ca":true},{"name":"John N. Allan","is_ca":false},{"name":"Jacqueline C. Barrientos","is_ca":false},{"name":"Paul M. Barr","is_ca":false},{"name":"Chunxue Shi","is_ca":false},{"name":"Anita Szoke","is_ca":false},{"name":"Christopher Abbazio","is_ca":false},{"name":"Gabriel Krigsfeld","is_ca":false},{"name":"Jan A. Burger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01802651987704014,"gpt":0.2991594278701664,"spread":0.2811329079931262,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002781237,0.0005019234,0.001231289,0.0003659495,0.00008007365,0.00008411188,0.0001862283,0.0002201545,0.00075181],"category_scores_gemma":[0.00008953889,0.0003495462,0.0002298331,0.002284223,0.00008893957,0.000204715,0.00007612271,0.0001899553,0.00002642728],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.07750218,"about_ca_system_score_gemma":0.01208776,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01382503,"about_ca_topic_score_gemma":0.02944111,"domain_scores_codex":[0.9965271,0.0001518744,0.0006598018,0.0008615395,0.001081315,0.0007184044],"domain_scores_gemma":[0.9981261,0.0002149193,0.0001488701,0.0008121195,0.0003152194,0.0003827012],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.04357077,0.004187282,0.4455148,0.003793202,0.03193404,0.01032584,0.01624374,0.4289308,0.001347704,0.0002759825,0.0009114895,0.01296442],"study_design_scores_gemma":[0.09174323,0.01739683,0.4360768,0.0025199,0.004386321,0.00003805094,0.0002974479,0.443859,0.002286345,0.00005113173,0.0002833326,0.001061547],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972122,0.0006946122,0.00004352802,0.0001919292,0.00005380187,0.001366785,0.0001463248,0.0001322263,0.0001586263],"genre_scores_gemma":[0.9953408,0.00005481473,0.0007746082,0.0001637702,0.0001187643,0.0001035145,0.001471699,0.0001047165,0.001867334],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06541442,"threshold_uncertainty_score":0.9998956,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386024076","doi":"10.1097/01.hs9.0000967492.06443.0a","title":"S145: VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 6-YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"","keywords":"Obinutuzumab; Venetoclax; Medicine; Chronic lymphocytic leukemia; Internal medicine; Tolerability; Chlorambucil; Bendamustine; Oncology; Hazard ratio; Interquartile range; Clinical endpoint; Leukemia; Gastroenterology; Randomized controlled trial; Cyclophosphamide; Chemotherapy; Adverse effect; Confidence interval","authors":[{"name":"Othman Al‐Sawaf","is_ca":false},{"name":"Sandra Robrecht","is_ca":false},{"name":"Can Zhang","is_ca":false},{"name":"Stefano Olivieri","is_ca":false},{"name":"Yi Meng Chang","is_ca":true},{"name":"Anna‐Maria Fink","is_ca":false},{"name":"Eugen Tausch","is_ca":false},{"name":"Christof Schneider","is_ca":false},{"name":"Matthias Ritgen","is_ca":false},{"name":"Karl‐Anton Kreuzer","is_ca":false},{"name":"Liliya Sivcheva","is_ca":false},{"name":"Carsten Utoft Niemann","is_ca":false},{"name":"Anthony P. Schwarer","is_ca":false},{"name":"Javier Loscertales","is_ca":false},{"name":"Robert Weinkove","is_ca":false},{"name":"Dirk Strumberg","is_ca":false},{"name":"Allanah Kilfoyle","is_ca":false},{"name":"Eva Diana Runkel","is_ca":true},{"name":"Barbara Eichhorst","is_ca":false},{"name":"Stephan Stilgenbauer","is_ca":false},{"name":"Yanwen Jiang","is_ca":false},{"name":"Michael Hallek","is_ca":false},{"name":"Kirsten Fischer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02367475763571688,"gpt":0.3104929278816977,"spread":0.2868181702459809,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001987775,0.0003913489,0.00140271,0.0001257368,0.0001933038,0.00003347228,0.0005338259,0.0002636437,0.0002069162],"category_scores_gemma":[0.002550913,0.0002526398,0.0006329545,0.001396195,0.0004067057,0.00006980717,0.0003265354,0.0003130006,0.0002633126],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.1219166,"about_ca_system_score_gemma":0.06929772,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002957791,"about_ca_topic_score_gemma":0.0004925134,"domain_scores_codex":[0.9957978,0.0004002736,0.001110714,0.0007297988,0.001021782,0.0009396693],"domain_scores_gemma":[0.9957898,0.001632696,0.000348108,0.001630423,0.0003738547,0.0002251576],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.719355,0.0005819807,0.0006285938,0.009697509,0.006417632,0.001041519,0.01399687,0.04472646,0.006185211,0.0016859,0.186848,0.008835256],"study_design_scores_gemma":[0.8672258,0.001418253,0.0002145408,0.000875882,0.0008360375,0.0001055684,0.001410083,0.1162544,0.007399514,0.0002336212,0.003715014,0.0003113067],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9825615,0.001127546,0.00002990358,0.0001612687,0.0003503516,0.01111372,0.00006186173,0.0003425977,0.004251297],"genre_scores_gemma":[0.9763194,0.0002430284,0.0001213835,0.00005707806,0.0003413322,0.0009795687,0.00008529203,0.0001158911,0.02173704],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.183133,"threshold_uncertainty_score":0.9999926,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2947040488","doi":"10.1097/hs9.0000000000000250","title":"A Simple RNA Target Capture NGS Strategy for Fusion Genes Assessment in the Diagnostics of Pediatric B‐cell Acute Lymphoblastic Leukemia","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; Canadian Thoracic Society","keywords":"Fusion gene; Computational biology; Gold standard (test); Gene; Fusion transcript; Fluorescence in situ hybridization; Molecular diagnostics; Biology; Bioinformatics; Medicine; Genetics; Internal medicine","authors":[{"name":"Andrea Grioni","is_ca":false},{"name":"Grazia Fazio","is_ca":false},{"name":"Silvia Rigamonti","is_ca":false},{"name":"Vojtěch Bystrý","is_ca":false},{"name":"Giulia Daniele","is_ca":false},{"name":"Zuzana Dostálová","is_ca":false},{"name":"Manuel Quadri","is_ca":false},{"name":"Claudia Saitta","is_ca":false},{"name":"Daniela Silvestri","is_ca":false},{"name":"Simona Songia","is_ca":false},{"name":"Clelia Tiziana Storlazzi","is_ca":false},{"name":"Andrea Biondi","is_ca":false},{"name":"Nikos Darzentas","is_ca":false},{"name":"Giovanni Cazzaniga","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01576470586151458,"gpt":0.2963564559634752,"spread":0.2805917501019606,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004452973,0.0003169534,0.0005870553,0.0001171973,0.00006740767,0.0000325553,0.0003892078,0.0002797641,0.0006290051],"category_scores_gemma":[0.0002207941,0.0002144515,0.0001862581,0.0005722733,0.00006811077,0.0000958833,0.0001331437,0.0003766294,0.00006573799],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009113384,"about_ca_system_score_gemma":0.003048914,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000180074,"about_ca_topic_score_gemma":0.0000436058,"domain_scores_codex":[0.9973828,0.0001001,0.0005697202,0.0004650308,0.0008389382,0.000643403],"domain_scores_gemma":[0.996828,0.00188542,0.0002191744,0.0006491799,0.0002594392,0.0001587681],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.005005155,0.005020544,0.4400915,0.01734923,0.001085124,0.002298074,0.007857784,0.02583808,0.1300717,0.005454456,0.3447693,0.01515904],"study_design_scores_gemma":[0.1263937,0.01551254,0.3113864,0.001386985,0.005665294,0.001022164,0.03792769,0.3804762,0.06763406,0.00822146,0.04004204,0.00433143],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888364,0.001966248,0.002360972,0.0002448988,0.0001769342,0.002230575,0.0001358134,0.00003748056,0.004010648],"genre_scores_gemma":[0.9937612,0.0009889338,0.003143,0.0002649401,0.0003506999,0.0001775964,0.0001728611,0.00006684323,0.001073868],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3546381,"threshold_uncertainty_score":0.8745078,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385666327","doi":"10.1097/01.hs9.0000967372.19440.62","title":"S115: CONSOLIDATION WITH BLINATUMOMAB IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AND MRD LEVEL IN ECOG-ACRIN E1910","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Blinatumomab; Internal medicine; Minimal residual disease; Oncology; Rituximab; Induction chemotherapy; Chemotherapy; Acute lymphocytic leukemia; Chemotherapy regimen; Lymphoblastic Leukemia; Leukemia; Lymphoma","authors":[{"name":"Mark R. Litzow","is_ca":false},{"name":"Zhuoxin Sun","is_ca":false},{"name":"Ryan J. Mattison","is_ca":false},{"name":"Elisabeth Paietta","is_ca":false},{"name":"Charles G. Mullighan","is_ca":false},{"name":"Kathryn G. Roberts","is_ca":false},{"name":"Yanming Zhang","is_ca":false},{"name":"Janis Racevskis","is_ca":false},{"name":"Cheryl L. Willman","is_ca":false},{"name":"Matthew J. Wieduwilt","is_ca":false},{"name":"Michaela Liedtke","is_ca":false},{"name":"Julie Bergeron","is_ca":true},{"name":"Hillard M. Lazarus","is_ca":false},{"name":"Dan Arber","is_ca":false},{"name":"Brent L. Wood","is_ca":false},{"name":"Jacob M. Rowe","is_ca":false},{"name":"Keith W. Pratz","is_ca":false},{"name":"Shira Dinner","is_ca":false},{"name":"Noelle V. Frey","is_ca":false},{"name":"Steve Gore","is_ca":false},{"name":"Bhavana Bhatnagar","is_ca":false},{"name":"Ehab Atallah","is_ca":false},{"name":"Geoffrey L. Uy","is_ca":false},{"name":"Deepa Jeyakumar","is_ca":false},{"name":"Tara L. Lin","is_ca":false},{"name":"Shejal Patel","is_ca":false},{"name":"Michelle A. Elliott","is_ca":false},{"name":"Anjali S. Advani","is_ca":false},{"name":"Daniel J. DeAngelo","is_ca":false},{"name":"Dimitrios Tzachanis","is_ca":false},{"name":"Pankit Vachhani","is_ca":false},{"name":"Rupali Bhave","is_ca":false},{"name":"Richard F. Little","is_ca":false},{"name":"Harry P. Erba","is_ca":false},{"name":"Richard M. Stone","is_ca":false},{"name":"Selina M. Luger","is_ca":false},{"name":"Martin S. Tallman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01744830779822663,"gpt":0.2722985419114596,"spread":0.254850234113233,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002552188,0.000277788,0.0005722096,0.0002345714,0.00003380759,0.0000350653,0.0001139284,0.000151336,0.0001515448],"category_scores_gemma":[0.000138756,0.000208174,0.00004561285,0.0006249098,0.000189515,0.0001840389,0.0001332715,0.0003389619,0.000005313974],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003738013,"about_ca_system_score_gemma":0.0004465444,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001606701,"about_ca_topic_score_gemma":0.002443408,"domain_scores_codex":[0.9981639,0.00008663442,0.0003464716,0.0004423163,0.0004914053,0.000469218],"domain_scores_gemma":[0.9988152,0.0003369284,0.0001234492,0.000423506,0.0001165201,0.0001844411],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009475654,0.0005806146,0.9436383,0.0006079298,0.000225451,0.001395714,0.001333902,0.0001639052,0.03555335,0.00003079507,0.0007037716,0.006290597],"study_design_scores_gemma":[0.03756919,0.003068606,0.9555283,0.000373489,0.00005847605,0.00002071598,0.0002983837,0.0007851392,0.001960393,0.0000784381,0.00002262226,0.000236305],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978395,0.0001190299,0.00001086223,0.00006182109,0.00003194759,0.0009534482,0.00007411314,0.00003920651,0.0008700542],"genre_scores_gemma":[0.997341,0.0002108354,0.0003222858,0.00002598744,0.00002287842,0.0000407568,0.000105785,0.00006555446,0.001864899],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03359296,"threshold_uncertainty_score":0.848909,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4378078281","doi":"10.1097/hs9.0000000000000886","title":"Bleeding and Thrombosis in Patients With Cirrhosis: What’s New?","year":2023,"lang":"en","type":"editorial","venue":"HemaSphere","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Cirrhosis; Thrombosis; Medicine; Internal medicine; Cardiology","authors":[{"name":"Ton Lisman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009926677538678964,"gpt":0.2461621774299515,"spread":0.2362354998912725,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005472219,0.0002201376,0.0003704373,0.00007433267,0.00003330881,0.00006914003,0.00004981118,0.0003406929,0.0001031241],"category_scores_gemma":[0.0000237488,0.0001811478,0.00004178487,0.0001949601,0.00002473871,0.0002853689,0.00001864223,0.000342289,0.00004881997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006598867,"about_ca_system_score_gemma":0.000242754,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002783299,"about_ca_topic_score_gemma":0.0001966616,"domain_scores_codex":[0.9986645,0.00001444304,0.0001894997,0.0003627371,0.000546104,0.0002227281],"domain_scores_gemma":[0.999326,0.0001790538,0.0000733143,0.0001623935,0.0000943743,0.0001648584],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0005188553,0.0001095131,0.077558,0.001400205,0.0004869213,0.00005750591,0.001040527,0.000001399465,0.000002664453,0.000006376859,0.9177515,0.001066517],"study_design_scores_gemma":[0.03283865,0.002139988,0.7850998,0.02787444,0.009222418,0.000001800317,0.003585551,0.0000272973,0.00007964193,0.0002130746,0.1372953,0.001622068],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.1262511,0.002005339,0.00001040718,0.0002452621,0.8694583,0.0009454314,0.0001315733,0.0002042649,0.0007483668],"genre_scores_gemma":[0.08128382,0.0109041,0.0002988764,0.0001575863,0.8988292,0.0001133897,0.005062826,0.000329209,0.003021002],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.7804562,"threshold_uncertainty_score":0.7386993,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4387899802","doi":"10.1097/hs9.0000000000000966","title":"Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM Study","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; University of Toronto","funders":"Sierra Oncology; MorphoSys; Cancer Research UK; Galecto; Incyte; Gilead Sciences; CTI Biopharma; Division of Materials Research; Celgene; Pfizer","keywords":"Myelofibrosis; Medicine; Quality of life (healthcare); Anemia; Ruxolitinib; Clinical endpoint; Danazol; Internal medicine; Physical therapy; Myeloproliferative neoplasm; Janus kinase 2; Clinical trial; Bone marrow","authors":[{"name":"Ruben A. Mesa","is_ca":false},{"name":"Claire Harrison","is_ca":false},{"name":"Jeanne Palmer","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Donal P. McLornan","is_ca":false},{"name":"Mary Frances McMullin","is_ca":false},{"name":"Jean‐Jacques Kiladjian","is_ca":false},{"name":"Lynda Foltz","is_ca":true},{"name":"Uwe Platzbecker","is_ca":false},{"name":"María Laura Fox","is_ca":false},{"name":"Adam J. Mead","is_ca":false},{"name":"David M. Ross","is_ca":false},{"name":"Stephen T. Oh","is_ca":false},{"name":"Andrew C. Perkins","is_ca":false},{"name":"Michael F. Leahy","is_ca":false},{"name":"Jun Kawashima","is_ca":false},{"name":"Sunhee Ro","is_ca":false},{"name":"Rafe Donahue","is_ca":false},{"name":"Boris Gorsh","is_ca":false},{"name":"Samineh Deheshi","is_ca":false},{"name":"Srđan Verstovšek","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02757746517641687,"gpt":0.2802369706173891,"spread":0.2526595054409723,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001909772,0.0001916951,0.0005524053,0.00003864834,0.00006034641,0.00001689034,0.0000355807,0.00004585479,0.00002504243],"category_scores_gemma":[0.0003847624,0.0001035562,0.00003052971,0.0002610876,0.00006648348,0.00005365324,0.00006957778,0.00008935711,0.000004291983],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002955498,"about_ca_system_score_gemma":0.00004514523,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00104936,"about_ca_topic_score_gemma":0.0007942434,"domain_scores_codex":[0.998284,0.0001276329,0.0006643683,0.0003511001,0.0003975746,0.0001752572],"domain_scores_gemma":[0.9985554,0.0006299366,0.0002699658,0.0003579243,0.00008138282,0.0001053848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006023023,0.0009108132,0.9920891,0.00006719353,0.0002991456,0.00001533898,0.004806166,0.0000040446,0.0000236189,0.00001046446,0.0002216204,0.0009501867],"study_design_scores_gemma":[0.01156757,0.0009177771,0.9816148,0.0002838148,0.0001184579,5.962089e-7,0.005233482,0.00004087571,0.00008992638,0.00002110215,0.000009531583,0.0001020095],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974785,0.0001722763,3.042533e-7,0.0005848573,0.00003142639,0.001495955,0.00009223584,0.00003845827,0.0001059181],"genre_scores_gemma":[0.9994171,0.00005053083,0.00008365169,0.0001291504,0.000008196891,0.0001482487,0.00009320096,0.00001682425,0.0000531274],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01096527,"threshold_uncertainty_score":0.4222899,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3005070954","doi":"10.1097/hs9.0000000000000319","title":"The Pediatric Acute Leukemia Fusion Oncogene ETO2‐GLIS2 Increases Self‐Renewal and Alters Differentiation in a Human Induced Pluripotent Stem Cells‐Derived Model","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institut National Du Cancer; Fondation pour la Recherche Médicale; Cancéropôle Ile de France; Agence Nationale de la Recherche; CNIB","keywords":"Induced pluripotent stem cell; Stem cell; Cell biology; Oncogene; Cancer research; Leukemia; Biology; Embryonic stem cell; Neuroscience; Immunology; Apoptosis; Cell cycle; Genetics; Gene","authors":[{"name":"Salvatore Nicola Bertuccio","is_ca":false},{"name":"Fabien Boudia","is_ca":false},{"name":"Marie Cambot","is_ca":false},{"name":"Cécile K. Lopez","is_ca":false},{"name":"Larissa Lordier","is_ca":false},{"name":"Alessandro Donada","is_ca":false},{"name":"Elie Robert","is_ca":false},{"name":"Cécile Thirant","is_ca":false},{"name":"Zakia Aid","is_ca":false},{"name":"Salvatore Serravalle","is_ca":false},{"name":"Annalisa Astolfi","is_ca":false},{"name":"Valentina Indio","is_ca":false},{"name":"Franco Locatelli","is_ca":false},{"name":"Andrea Pession","is_ca":false},{"name":"William Vainchenker","is_ca":false},{"name":"Riccardo Masetti","is_ca":false},{"name":"Hana Raslová","is_ca":false},{"name":"Thomas Mercher","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007684411805674912,"gpt":0.2162401684229523,"spread":0.2085557566172773,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009999681,0.0001818852,0.0001467725,0.00003222163,0.0001386365,0.00003779223,0.0001421436,0.0001726526,0.00001324218],"category_scores_gemma":[0.000006351069,0.0001422964,0.00006154301,0.00008777291,0.00001940305,0.00001075782,0.0001599353,0.0001137298,0.000006435377],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006523335,"about_ca_system_score_gemma":0.0001094511,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008901367,"about_ca_topic_score_gemma":0.000144933,"domain_scores_codex":[0.9989249,0.00008044169,0.0002533164,0.0003514289,0.0001663549,0.0002235564],"domain_scores_gemma":[0.9994345,0.00001217857,0.0001307583,0.0002933747,0.00004704267,0.00008217461],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00006018651,0.00005258729,0.003669321,0.00002420293,0.00002569067,0.000001364956,0.00006874329,0.0001791355,0.9950734,0.00004112825,0.0002085221,0.0005957666],"study_design_scores_gemma":[0.001511107,0.0002526612,0.001225346,0.00001974536,0.00004370545,0.000005361489,0.0002244396,0.004923293,0.9912217,0.00007390263,0.0002258658,0.000272883],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984669,0.0006372836,0.0001099298,0.00004326705,0.0001090207,0.0004190848,0.00000922588,0.00002238024,0.0001829107],"genre_scores_gemma":[0.9981725,0.0008608908,0.0001549367,0.00007964051,0.0001268733,0.00003558535,0.00006403009,0.0000233285,0.000482227],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004744157,"threshold_uncertainty_score":0.5802677,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283326517","doi":"10.1097/01.hs9.0000843644.02496.66","title":"S188: TECLISTAMAB IN COMBINATION WITH DARATUMUMAB, A NOVEL, IMMUNOTHERAPY-BASED APPROACH FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Daratumumab; Medicine; Internal medicine; Oncology; Multiple myeloma; Adverse effect; Phases of clinical research; Refractory (planetary science); Clinical trial; Bortezomib","authors":[{"name":"Paula Rodríguez‐Otero","is_ca":false},{"name":"Anita D’Souza","is_ca":false},{"name":"Donna Reece","is_ca":true},{"name":"N. W. van de Donk","is_ca":false},{"name":"Ajai Chari","is_ca":false},{"name":"Aparna Krishnan","is_ca":false},{"name":"Thomas G. Martin","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Daniel Morillo","is_ca":false},{"name":"David D. Hurd","is_ca":false},{"name":"Laura Rosiñol","is_ca":false},{"name":"Ralph Wäsch","is_ca":false},{"name":"Deeksha Vishwamitra","is_ca":false},{"name":"Shu-Chen Lin","is_ca":false},{"name":"Thomas J. Prior","is_ca":false},{"name":"Lien Vandenberk","is_ca":false},{"name":"M.-A. D. Smit","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Bhagirathbhai Dholaria","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03588206454185491,"gpt":0.3080620892896637,"spread":0.2721800247478088,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002688325,0.0002578721,0.0004406534,0.0001415067,0.0003125897,0.00001657753,0.0001575207,0.00007029578,0.0000999096],"category_scores_gemma":[0.0000703742,0.0001638535,0.0001417101,0.0005677259,0.0001160638,0.00005841336,0.00002350733,0.0002025973,0.000001251161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005956608,"about_ca_system_score_gemma":0.0003923757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000464996,"about_ca_topic_score_gemma":0.0001423935,"domain_scores_codex":[0.9981762,0.0001028074,0.000437453,0.0004269386,0.0004878434,0.0003687232],"domain_scores_gemma":[0.9984469,0.0004522394,0.0002069105,0.0006553283,0.0001571002,0.00008149917],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4144123,0.2726951,0.02081575,0.0008676185,0.003393827,0.0003917471,0.005264855,0.007186006,0.03948285,0.0007357068,0.005013553,0.2297406],"study_design_scores_gemma":[0.6621848,0.03387045,0.01181032,0.0001506592,0.0003189195,0.00004104717,0.003596973,0.1698995,0.02093859,0.00002135923,0.09669039,0.00047704],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9594774,0.004302337,0.01629328,0.00137496,0.0001463291,0.01257668,0.002123184,0.0001587624,0.003547057],"genre_scores_gemma":[0.9863131,0.00005120038,0.007209936,0.00006382853,0.00001951776,0.002218717,0.002371971,0.00004122732,0.0017105],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2477724,"threshold_uncertainty_score":0.6681753,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386024134","doi":"10.1097/01.hs9.0000967716.49281.3f","title":"S201: FINAL 7-YEAR FOLLOW UP AND RETREATMENT SUBSTUDY ANALYSIS OF MURANO: VENETOCLAX-RITUXIMAB (VENR)-TREATED PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL)","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Bendamustine; Hazard ratio; Rituximab; Gastroenterology; Confidence interval; Neutropenia; Minimal residual disease; Chronic lymphocytic leukemia; Surgery; Oncology; Leukemia; Chemotherapy; Lymphoma","authors":[{"name":"Arnon P. Kater","is_ca":false},{"name":"Rosemary Harrup","is_ca":false},{"name":"Thomas J. Kipps","is_ca":false},{"name":"Barbara Eichhorst","is_ca":false},{"name":"Carolyn Owen","is_ca":true},{"name":"Sarit Assouline","is_ca":true},{"name":"Nicole Lamanna","is_ca":false},{"name":"Tadeusz Robak","is_ca":false},{"name":"Javier de la Serna","is_ca":false},{"name":"Ulrich Jaeger","is_ca":false},{"name":"Guillaume Cartron","is_ca":false},{"name":"Marco Montillo","is_ca":false},{"name":"Clemens Mellink","is_ca":false},{"name":"Brenda Chyla","is_ca":false},{"name":"Maria Thadani‐Mulero","is_ca":false},{"name":"Marcus Lefebure","is_ca":false},{"name":"Yanwen Jiang","is_ca":true},{"name":"Rosemary Millen","is_ca":false},{"name":"Michelle Boyer","is_ca":false},{"name":"John F. Seymour","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02021042823609262,"gpt":0.2684018237487544,"spread":0.2481913955126618,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002988683,0.0004766412,0.001262283,0.000466639,0.0001589524,0.00003314086,0.0002180017,0.0002784406,0.0007390779],"category_scores_gemma":[0.0001366836,0.000372122,0.0003036048,0.002911757,0.0003022268,0.0001386192,0.0001713747,0.0002977771,0.0002187867],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.06528202,"about_ca_system_score_gemma":0.01393861,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003205418,"about_ca_topic_score_gemma":0.0008660469,"domain_scores_codex":[0.9962741,0.0001240015,0.0006419359,0.0008723799,0.001252175,0.0008354358],"domain_scores_gemma":[0.9976099,0.0002952325,0.0002565665,0.001116821,0.0003398581,0.0003816539],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01730387,0.001368558,0.9192733,0.003002613,0.02315977,0.002693231,0.00397127,0.007881851,0.001617492,0.0001524676,0.008070708,0.01150493],"study_design_scores_gemma":[0.2735885,0.008341389,0.5990325,0.001386002,0.01116662,0.00008490948,0.001474768,0.0979112,0.003804122,0.00003318488,0.001999544,0.001177228],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961671,0.001392661,0.000008543562,0.00001916957,0.0000921153,0.001196301,0.00006519183,0.0001994142,0.0008595473],"genre_scores_gemma":[0.9936858,0.000378027,0.000133029,0.00002692825,0.00006210385,0.0001134077,0.000525842,0.0001003884,0.004974483],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3202407,"threshold_uncertainty_score":0.9998731,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283312353","doi":"10.1097/01.hs9.0000843628.63947.e4","title":"S184: EVALUATING TECLISTAMAB IN PATIENTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA FOLLOWING EXPOSURE TO OTHER B-CELL MATURATION ANTIGEN (BCMA)-TARGETED AGENTS","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Institute of Cancer Research","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Cytokine release syndrome; Chimeric antigen receptor; Cohort; Oncology; Antigen; Gastroenterology; Immunology; Cancer; Immunotherapy","authors":[{"name":"C. Touzeau","is_ca":false},{"name":"A. Krishnan","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"A. Perrot","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false},{"name":"Salomon Manier","is_ca":false},{"name":"M. Cavo","is_ca":false},{"name":"Carmen Martínez‐Chamorro","is_ca":false},{"name":"A. Nooka","is_ca":false},{"name":"T. Martin","is_ca":false},{"name":"L. Karlin","is_ca":false},{"name":"Xavier Leleu","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Britta Besemer","is_ca":false},{"name":"Lixia Pei","is_ca":false},{"name":"R. Verona","is_ca":false},{"name":"Sarah Girgis","is_ca":false},{"name":"C. Uhlar","is_ca":false},{"name":"Rachel Kobos","is_ca":false},{"name":"A. Garfall","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02526965690813318,"gpt":0.2987480830311138,"spread":0.2734784261229806,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006909692,0.0002677094,0.0003961411,0.0001802722,0.0002596507,0.00003893945,0.0002047694,0.0001019582,0.008390976],"category_scores_gemma":[0.0001890559,0.0002465055,0.0001274601,0.0007876306,0.00002301853,0.0001534606,0.0001673381,0.0006379975,0.00007816631],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006328552,"about_ca_system_score_gemma":0.000201329,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001978401,"about_ca_topic_score_gemma":0.0001301858,"domain_scores_codex":[0.9965715,0.0003122961,0.0004519547,0.0005880362,0.001521561,0.0005545841],"domain_scores_gemma":[0.9987872,0.0001161153,0.0001405502,0.0006175624,0.0001434979,0.0001951196],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00644239,0.001255403,0.8110858,0.0001341282,0.0001331665,0.0001665419,0.003876014,0.0008456726,0.1554346,0.000002526554,0.00234509,0.01827872],"study_design_scores_gemma":[0.0287889,0.006485465,0.9138435,0.0003718259,0.000080639,0.000009949596,0.004162007,0.001751652,0.0116524,0.00001660496,0.03206521,0.0007718434],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936982,0.0003110488,0.00003394322,0.0001462831,0.0002117262,0.00204042,0.0000262343,0.00009514454,0.003436983],"genre_scores_gemma":[0.9873744,0.000003120455,0.002269224,0.0004848336,0.00008141463,0.0002480157,0.0001764831,0.0001271489,0.009235382],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1437822,"threshold_uncertainty_score":0.9999987,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2951457160","doi":"10.1097/01.hs9.0000559376.17429.23","title":"PF291 A PHASE 1B/2 CLINICAL STUDY OF TARGETED IDH1 INHIBITION WITH IVOSIDENIB, IN COMBINATION WITH THE BCL‐2 INHIBITOR VENETOCLAX, FOR PATIENTS WITH IDH1‐MUTATED (MIDH1) MYELOID MALIGNANCIES","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Venetoclax; Ven; IDH1; Medicine; Tolerability; Internal medicine; Oncology; Refractory (planetary science); Myeloid; Myeloid leukemia; Gastroenterology; Leukemia; Adverse effect; Chronic lymphocytic leukemia; Chemistry; Biology; Mutation","authors":[{"name":"Courtney D. DiNardo","is_ca":false},{"name":"Kazuto Takahashi","is_ca":false},{"name":"Tapan M. Kadia","is_ca":false},{"name":"Sanam Loghavi","is_ca":false},{"name":"Kiran Naqvi","is_ca":false},{"name":"P. Bose","is_ca":false},{"name":"Naval Daver","is_ca":false},{"name":"George D. Tippett","is_ca":false},{"name":"Gautam Borthakur","is_ca":false},{"name":"Jörge E. Cortes","is_ca":false},{"name":"Steven M. Chan","is_ca":true},{"name":"Lynn Quek","is_ca":false},{"name":"Paresh Vyas","is_ca":false},{"name":"H. Kantarjian","is_ca":false},{"name":"Marina Konopleva","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01650303000590497,"gpt":0.3079110771014915,"spread":0.2914080470955865,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007025887,0.0003726215,0.000806548,0.0001570879,0.0001106505,0.00003713822,0.0001812269,0.0001917337,0.00009902704],"category_scores_gemma":[0.0001610714,0.0002139986,0.00007310937,0.001051376,0.0002644763,0.0002762097,0.00007768338,0.0005899632,0.00002127332],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000477206,"about_ca_system_score_gemma":0.0009127735,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002042691,"about_ca_topic_score_gemma":0.000586343,"domain_scores_codex":[0.9967034,0.0002555312,0.000760585,0.0006641327,0.001074096,0.0005422104],"domain_scores_gemma":[0.9972762,0.0004028892,0.0004438827,0.0006577076,0.001051257,0.0001680713],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.0627798,0.0218297,0.8846546,0.001169869,0.0008450484,0.0002361829,0.005416804,0.0004508967,0.01416176,0.0001623786,0.004359453,0.00393348],"study_design_scores_gemma":[0.4447483,0.1551341,0.3274167,0.003455938,0.0008674199,0.00008333033,0.0264338,0.004841928,0.03410788,0.00008016949,0.001492648,0.001337838],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909205,0.00007462284,0.0002123132,0.000376126,0.00005993248,0.008103163,0.00004272061,0.00006764227,0.0001429682],"genre_scores_gemma":[0.9975165,0.000008966067,0.0008578945,0.0001588947,0.00007737512,0.0005656161,0.0002992396,0.0001014657,0.0004140426],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5572379,"threshold_uncertainty_score":0.8726611,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385667297","doi":"10.1097/01.hs9.0000968132.86513.06","title":"S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY OF RECOMBINANT ADAMTS13 IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital; Western University","funders":"","keywords":"Medicine; ADAMTS13; Thrombotic thrombocytopenic purpura; Placebo; Internal medicine; Gastroenterology; Clinical endpoint; Adverse effect; Thrombotic microangiopathy; Randomized controlled trial; Platelet; Disease; Pathology","authors":[{"name":"Marie Scully","is_ca":false},{"name":"Jovanna Baptista","is_ca":false},{"name":"Indranil Bhattacharya","is_ca":false},{"name":"Spero R. Cataland","is_ca":false},{"name":"Paul Coppo","is_ca":false},{"name":"Loredana Cuccia","is_ca":false},{"name":"Tina Dutt","is_ca":false},{"name":"Shih‐Han S. Huang","is_ca":true},{"name":"Cristina Pascual","is_ca":false},{"name":"María Eva Mingot‐Castellano","is_ca":false},{"name":"Aric Parnes","is_ca":false},{"name":"Katerina Pavenski","is_ca":true},{"name":"Kavitha Rajavel","is_ca":false},{"name":"Isidro Jarque","is_ca":false},{"name":"Linda T. Wang","is_ca":false},{"name":"Miguel Fernández Zarzoso","is_ca":false},{"name":"Andy Z. X. Zhu","is_ca":false},{"name":"Björn Mellgård","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02440366224807412,"gpt":0.2909944128602566,"spread":0.2665907506121825,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008852269,0.0004562746,0.002196326,0.0002529719,0.0001461714,0.00002648668,0.0004755413,0.0001712796,0.002758079],"category_scores_gemma":[0.0001772001,0.0003244852,0.000260783,0.0006352767,0.0002052504,0.0001898578,0.0002441619,0.0003089392,0.0008091716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009731975,"about_ca_system_score_gemma":0.0001010405,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004579512,"about_ca_topic_score_gemma":0.0005707,"domain_scores_codex":[0.9960581,0.000969978,0.001492636,0.0006048239,0.0002009915,0.0006734399],"domain_scores_gemma":[0.9973835,0.0009551169,0.0006468707,0.0007644289,0.0001995542,0.00005049767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9109066,0.009628217,0.07249175,0.0001516049,0.002085735,0.00003379825,0.002116231,0.00009953657,0.0009060774,0.00005474964,0.001302996,0.000222726],"study_design_scores_gemma":[0.9676386,0.00140714,0.02461364,0.0002945119,0.0004477174,0.000001805302,0.004683807,0.0000704804,0.0003808863,0.00001668975,0.0000818635,0.0003628713],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859738,0.0007456191,0.000005668988,0.00005095654,0.0009708833,0.01176251,0.00003890692,0.0001526853,0.000298908],"genre_scores_gemma":[0.9969299,0.00002587972,0.00001069412,0.00001674275,0.00001170522,0.001452307,0.000525785,0.00005763712,0.000969362],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05673201,"threshold_uncertainty_score":0.9999688,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2950620394","doi":"10.1097/01.hs9.0000561796.30124.a4","title":"S879 RESULTS OF ASTRAL‐1 STUDY, A PHASE 3 RANDOMIZED TRIAL OF GUADECITABINE (G) VS TREATMENT CHOICE (TC) IN TREATMENT NAÏVE ACUTE MYELOID LEUKEMIA (TN‐AML) NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY (IC)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Decitabine; Internal medicine; Clinical endpoint; Cytarabine; Randomized controlled trial; Regimen; Induction chemotherapy; Oncology; Gastroenterology; Chemotherapy; Surgery","authors":[{"name":"Pierre Fenaux","is_ca":false},{"name":"Marco De Gobbi","is_ca":false},{"name":"Patricia Kropf","is_ca":false},{"name":"Jiřı́ Mayer","is_ca":false},{"name":"G.J. Roboz","is_ca":false},{"name":"Hartmut Döhner","is_ca":false},{"name":"J Krauter","is_ca":false},{"name":"Konstanze Döhner","is_ca":false},{"name":"Tadeusz Robak","is_ca":false},{"name":"H. Kantarjian","is_ca":false},{"name":"Jan Novák","is_ca":false},{"name":"W.W. Jedrzejczak","is_ca":false},{"name":"Xavier Thomas","is_ca":false},{"name":"Mario Ojeda‐Uribe","is_ca":false},{"name":"Yoshiyasu Miyazaki","is_ca":false},{"name":"Shih-Peng Yeh","is_ca":false},{"name":"Joseph Brandwein","is_ca":true},{"name":"Liana Gercheva","is_ca":false},{"name":"Judit Demeter","is_ca":false},{"name":"Ewen A. Griffiths","is_ca":false},{"name":"K Yee","is_ca":true},{"name":"Mohamed Azab","is_ca":false},{"name":"Jean‐Pierre J. Issa","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03473661491423022,"gpt":0.3619602162914029,"spread":0.3272236013771727,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001109428,0.0007112998,0.003653042,0.0003328299,0.00005094342,0.00002181059,0.0003108768,0.0003228406,0.0003213056],"category_scores_gemma":[0.001010835,0.0004994931,0.0009154184,0.0006398528,0.000226636,0.0001453927,0.00007619598,0.0003029477,0.00004966025],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002692611,"about_ca_system_score_gemma":0.001676247,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003179727,"about_ca_topic_score_gemma":0.0003523414,"domain_scores_codex":[0.9951363,0.00033116,0.00196898,0.0009965251,0.0007439044,0.0008231106],"domain_scores_gemma":[0.9947783,0.002110452,0.0007423189,0.001285231,0.0008366204,0.0002471268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9210572,0.005383587,0.0002517357,0.0001792754,0.00286109,0.00008454725,0.004840673,0.00003663373,0.04688104,0.00002123594,0.001438993,0.01696397],"study_design_scores_gemma":[0.7677485,0.03266149,0.0001570868,0.0002424062,0.0007626661,0.00001908683,0.002705367,0.0006644326,0.1917008,0.00002121539,0.003037528,0.0002793244],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9754093,0.0004270462,0.00005918652,0.001389707,0.0002562076,0.02090269,0.0003362811,0.00005854683,0.001160991],"genre_scores_gemma":[0.9821744,0.001031225,0.001846864,0.0001761165,0.0002954349,0.001832034,0.0003292458,0.0001286179,0.01218606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1533087,"threshold_uncertainty_score":0.9997457,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2953077540","doi":"10.1097/01.hs9.0000562152.07779.48","title":"PS962 PHASE 1 RESULTS OF ZUMA‐4: KTE‐X19, AN ANTI‐CD19 CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN PEDIATRIC AND ADOLESCENT PATIENTS WITH RELAPSED/REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Refractory (planetary science); Gastroenterology; Bone marrow; Acute lymphocytic leukemia; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Immunology; Leukemia; Lymphoblastic Leukemia; Biology","authors":[{"name":"Alan S. Wayne","is_ca":false},{"name":"Van Huynh","is_ca":true},{"name":"Nobuko Hijiya","is_ca":true},{"name":"Rayne H. Rouce","is_ca":true},{"name":"Patrick A. Brown","is_ca":false},{"name":"Joerg Krueger","is_ca":true},{"name":"Michael Rytting","is_ca":true},{"name":"Carrie L. Kitko","is_ca":false},{"name":"Edward Ziga","is_ca":true},{"name":"Michelle L. Hermiston","is_ca":true},{"name":"Morgan K. Richards","is_ca":false},{"name":"André Baruchel","is_ca":false},{"name":"Tong Shen","is_ca":true},{"name":"Lovely Goyal","is_ca":false},{"name":"Remus Vezan","is_ca":true},{"name":"Richa Jain","is_ca":true},{"name":"D.W. Lee","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00894242772849638,"gpt":0.2504569139496639,"spread":0.2415144862211675,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000343128,0.0005136189,0.000885083,0.000302274,0.00007291356,0.00002967458,0.0003224252,0.0003247226,0.00037197],"category_scores_gemma":[0.00005074847,0.0004005826,0.0001040106,0.0008870622,0.0001540606,0.0003298806,0.0001352788,0.0007195733,0.0001799953],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000691837,"about_ca_system_score_gemma":0.001230938,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001605643,"about_ca_topic_score_gemma":0.00001226118,"domain_scores_codex":[0.996381,0.0001968131,0.0007876218,0.0009614975,0.0008884618,0.0007846155],"domain_scores_gemma":[0.9976463,0.000158017,0.0004494693,0.0009938759,0.0002931448,0.0004591814],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0202638,0.006130368,0.8514506,0.001606729,0.000148335,0.0001839025,0.001765201,0.00007069776,0.09751571,0.000002561124,0.01209822,0.00876385],"study_design_scores_gemma":[0.1614009,0.0200653,0.7468747,0.0007589007,0.0003051894,0.00003513211,0.0009091032,0.001166245,0.06142974,0.000007065507,0.005692522,0.001355167],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947306,0.001162058,0.0000137672,0.00005077722,0.0001635728,0.001796534,0.0001296725,0.00007131371,0.001881735],"genre_scores_gemma":[0.9924441,0.003920072,0.0009614961,0.0001672961,0.0001631706,0.00002419238,0.0003045037,0.0001385054,0.001876678],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1411371,"threshold_uncertainty_score":0.9998446,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283326697","doi":"10.1097/01.hs9.0000843684.97625.7e","title":"S198: BET INHIBITOR PELABRESIB (CPI-0610) COMBINED WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS — JAK INHIBITOR-NAÏVE OR WITH SUBOPTIMAL RESPONSE TO RUXOLITINIB — PRELIMINARY DATA FROM THE MANIFEST STUDY","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Internal medicine; Myeloproliferative neoplasm; Oncology; Bone marrow","authors":[{"name":"John Mascarenhas","is_ca":false},{"name":"Marina Kremyanskaya","is_ca":false},{"name":"Andrea Patriarca","is_ca":false},{"name":"Claire Harrison","is_ca":false},{"name":"Prithviraj Bose","is_ca":false},{"name":"Raajit K. Rampal","is_ca":false},{"name":"Francesca Palandri","is_ca":false},{"name":"Timothy Devos","is_ca":false},{"name":"Francesco Passamonti","is_ca":false},{"name":"Gabriella Hobbs","is_ca":false},{"name":"Moshe Talpaz","is_ca":false},{"name":"Alessandro M. Vannucchi","is_ca":false},{"name":"Jean‐Jacques Kiladjian","is_ca":false},{"name":"Srđan Verstovšek","is_ca":false},{"name":"Ronald Hoffman","is_ca":false},{"name":"Mohamed E. Salama","is_ca":false},{"name":"Dong Chen","is_ca":false},{"name":"Pietro Taverna","is_ca":false},{"name":"A. Chang","is_ca":false},{"name":"Gozde Colak","is_ca":false},{"name":"Sandra Klein","is_ca":false},{"name":"Vikas Gupta","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02699854354408923,"gpt":0.266576492253164,"spread":0.2395779487090748,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006503589,0.0008062852,0.001041142,0.0001374477,0.0006338519,0.0001314522,0.000660127,0.00009377904,0.00169183],"category_scores_gemma":[0.0001877456,0.0004491476,0.00006787417,0.001014191,0.0001785776,0.0003120188,0.0009646906,0.0007424924,0.00007737806],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004555565,"about_ca_system_score_gemma":0.000768804,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009100952,"about_ca_topic_score_gemma":0.002771225,"domain_scores_codex":[0.9941795,0.0008145047,0.0007667155,0.001613223,0.001748251,0.0008777338],"domain_scores_gemma":[0.9954315,0.001222831,0.0003209549,0.002261956,0.0002939061,0.0004687997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2107571,0.008112353,0.7674115,0.00005605328,0.0004784074,0.001580238,0.004011159,0.00008258043,0.00002894579,0.00002379805,0.007080568,0.000377301],"study_design_scores_gemma":[0.03058765,0.06890293,0.8797159,0.0006827813,0.0005612932,0.00009069586,0.01555507,0.0000559539,0.0003623497,0.000004205091,0.002849285,0.0006319398],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98752,0.0001107847,0.000005093715,0.002738694,0.0001148227,0.006965617,0.001979394,0.0001254618,0.0004401639],"genre_scores_gemma":[0.9910964,0.000005159958,0.002334008,0.001007853,0.0002203622,0.002239444,0.001813075,0.0001828154,0.001100823],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1801694,"threshold_uncertainty_score":0.999796,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386024051","doi":"10.1097/01.hs9.0000967672.15362.d7","title":"S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Health Services; McGill University","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Oncology; Lenalidomide; Regimen; Expanded access","authors":[{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Daniel Morillo","is_ca":false},{"name":"Moshe E. Gatt","is_ca":false},{"name":"Michaël Sébag","is_ca":true},{"name":"Kihyun Kım","is_ca":false},{"name":"Chang‐Ki Min","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Enrique M. Ocio","is_ca":false},{"name":"Sung‐Soo Yoon","is_ca":false},{"name":"Yaël C. Cohen","is_ca":false},{"name":"Michael Chu","is_ca":true},{"name":"Paula Rodríguez‐Otero","is_ca":false},{"name":"Irit Avivi","is_ca":false},{"name":"Yue Guo","is_ca":false},{"name":"Maria Krevvata","is_ca":false},{"name":"Michelle Peterson","is_ca":false},{"name":"Melissa Beelen","is_ca":false},{"name":"Jill Vanak","is_ca":false},{"name":"Arnob Banerjee","is_ca":false},{"name":"Hila Magen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01469667351667762,"gpt":0.2448089160460415,"spread":0.2301122425293639,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004629378,0.0005306916,0.0006695639,0.0001265017,0.0004474858,0.00009587134,0.0002492635,0.0001730388,0.0001078132],"category_scores_gemma":[0.001670008,0.0003126035,0.00007173914,0.000952916,0.0002273828,0.0002014936,0.0002151056,0.0007071405,0.0001379825],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002720229,"about_ca_system_score_gemma":0.0001517432,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003953477,"about_ca_topic_score_gemma":0.01384385,"domain_scores_codex":[0.9960447,0.0002231093,0.0006287043,0.001080199,0.001150272,0.0008730429],"domain_scores_gemma":[0.9963909,0.001836307,0.000234145,0.0009128269,0.0002590216,0.0003668171],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01782329,0.002123157,0.952261,0.00009794274,0.0004675698,0.004019422,0.004471352,0.0001773256,0.00012516,0.000001474692,0.002158739,0.01627353],"study_design_scores_gemma":[0.05376636,0.005357316,0.9232613,0.0007437002,0.0001559342,0.00002924646,0.007500613,0.003109805,0.0002664069,0.000009145233,0.005312648,0.0004875083],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944704,0.0003552597,0.000004032497,0.0005266861,0.00006877521,0.002956595,0.000268396,0.0002853915,0.001064448],"genre_scores_gemma":[0.9967368,0.00008898172,0.0006457355,0.0000775709,0.0001279942,0.0002272702,0.0006658407,0.00012268,0.001307122],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03594307,"threshold_uncertainty_score":0.9999326,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2950944873","doi":"10.1097/01.hs9.0000563756.72895.a3","title":"PS1370 ELOTUZUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: EFFICACY RESULTS AFTER ADDITIONAL FOLLOW‐UP OF THE PHASE 2, RANDOMIZED ELOQUENT‐3 STUDY","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Pomalidomide; Lenalidomide; Medicine; Internal medicine; Dexamethasone; Oncology; Multiple myeloma; Combination therapy; Ixazomib; Refractory (planetary science); Progression-free survival; Bortezomib; Overall survival; Carfilzomib","authors":[{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Dominik Dytfeld","is_ca":false},{"name":"Sebastian Grosicki","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Naoki Takezako","is_ca":false},{"name":"Mitsuo Hori","is_ca":false},{"name":"Xavier Leleu","is_ca":false},{"name":"Richard LeBlanc","is_ca":true},{"name":"Kazuyuki Suzuki","is_ca":false},{"name":"Marc‐Steffen Raab","is_ca":false},{"name":"Paul G. Richardson","is_ca":false},{"name":"Mihaela Popa McKiver","is_ca":false},{"name":"Ying‐Ming Jou","is_ca":false},{"name":"Suresh G. Shelat","is_ca":false},{"name":"Michael Robbins","is_ca":false},{"name":"B. Rafferty","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02534817731838447,"gpt":0.3125158143310527,"spread":0.2871676370126683,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007231886,0.0003560147,0.001107327,0.00007003103,0.0001337552,0.00002803131,0.0001710411,0.0001542683,0.002315227],"category_scores_gemma":[0.002949822,0.0002244146,0.0004791973,0.0002175069,0.0002382337,0.0001172801,0.0001394575,0.0002909593,0.00006878858],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001841027,"about_ca_system_score_gemma":0.0003392959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001496387,"about_ca_topic_score_gemma":0.0001051376,"domain_scores_codex":[0.9970077,0.0003896262,0.0007398404,0.0006314882,0.0007323264,0.0004990094],"domain_scores_gemma":[0.9946086,0.003738374,0.0003066109,0.0008057432,0.0002610417,0.0002796034],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9584505,0.005636859,0.01093331,0.0003621524,0.002246628,0.0001517647,0.002033594,0.000008059997,0.001531607,0.00007913051,0.007139792,0.0114266],"study_design_scores_gemma":[0.9449973,0.002103023,0.04353227,0.0003995376,0.0005126579,0.00004338532,0.001018168,0.001027895,0.001467883,0.00005077542,0.004586548,0.0002605917],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865555,0.0009755156,0.00004688995,0.0002078472,0.0002535142,0.008808246,0.00157997,0.00005031444,0.001522179],"genre_scores_gemma":[0.9860076,0.00002853341,0.001784904,0.0000787795,0.0001111356,0.001441786,0.0004535557,0.00006202002,0.01003163],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03259896,"threshold_uncertainty_score":0.9985968,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2949764170","doi":"10.1097/01.hs9.0000564104.83392.dc","title":"PS1460 LONG-TERM FOLLOW UP OF JAK INHIBITOR (JAKI) TREATED PATIENTS WITH MYELOFIBROSIS: IMPACT OF MOLECULAR ENHANCED INTEGRATED SCORING SYSTEMS AND TYPE OF JAKI THERAPY FAILURE ON SURVIVAL","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Term (time); Medicine; Ruxolitinib; Internal medicine; Oncology; Physics","authors":[{"name":"J. Regis McNamara","is_ca":true},{"name":"Jennifer L. Spiegel","is_ca":false},{"name":"Wei Xu","is_ca":true},{"name":"Julianna Kennedy","is_ca":true},{"name":"Ana Luíza Ferreira de Arruda","is_ca":true},{"name":"Mengyao Yu","is_ca":true},{"name":"Jaime O. Claudio","is_ca":true},{"name":"Nancy Siddiq","is_ca":true},{"name":"Verna Cheung","is_ca":true},{"name":"Sabrina Malik","is_ca":true},{"name":"Anne Tierens","is_ca":true},{"name":"Dawn Maze","is_ca":true},{"name":"Hassan Sibai","is_ca":true},{"name":"Vedant Gupta","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01446729713172497,"gpt":0.2683572335645055,"spread":0.2538899364327805,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007448268,0.0003443304,0.0009547302,0.00008599595,0.00002229372,0.00001232461,0.00005712612,0.0001389953,0.000183089],"category_scores_gemma":[0.00002993474,0.0002099851,0.0001501474,0.0003475435,0.00006470278,0.00007370159,0.00002026746,0.0001203734,0.000006619134],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009337033,"about_ca_system_score_gemma":0.0001307302,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003060647,"about_ca_topic_score_gemma":0.00004167091,"domain_scores_codex":[0.9984468,0.00008478881,0.0004540341,0.0003599983,0.000423436,0.0002309404],"domain_scores_gemma":[0.9984584,0.00008645688,0.0003621757,0.000398043,0.0005753469,0.000119606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00392768,0.0007720687,0.877757,0.0004508134,0.0009214592,0.00001149707,0.0003238173,0.00005555951,0.1143076,0.00004898012,0.00002873023,0.001394875],"study_design_scores_gemma":[0.009203213,0.008938112,0.5293247,0.002949358,0.0001310113,0.00000331392,0.0001655768,0.00002232078,0.4490953,0.000001049991,0.00000465376,0.0001613914],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972122,0.0007483559,0.00001559985,0.00001101348,0.0001246681,0.001434294,0.00005941135,0.00002167973,0.000372753],"genre_scores_gemma":[0.9993646,0.0001158149,0.0001044585,0.000007027845,0.00001839452,0.00004099827,0.000116987,0.00004860383,0.0001830896],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3484322,"threshold_uncertainty_score":0.8562943,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385644849","doi":"10.1097/01.hs9.0000967680.90062.ca","title":"S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Medicine; Internal medicine; Oncology; Refractory (planetary science); CD38; Gastroenterology; Lenalidomide; Multiple myeloma; CD34","authors":[{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Katja Weisel","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Tom Martin","is_ca":false},{"name":"Daniel Morillo","is_ca":false},{"name":"Donna Reece","is_ca":true},{"name":"Paula Rodríguez‐Otero","is_ca":false},{"name":"Manisha Bhutani","is_ca":false},{"name":"Anita D’Souza","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Laura Rosiñol Dachs","is_ca":false},{"name":"Bhagirathbhai Dholaria","is_ca":false},{"name":"Kalpana Bakshi","is_ca":false},{"name":"Lijuan Kang","is_ca":false},{"name":"Lien Vandenberk","is_ca":false},{"name":"Damiette Smit","is_ca":false},{"name":"Ralph Wäsch","is_ca":false},{"name":"Niels W.C.J. van de Donk","is_ca":false},{"name":"Ajai Chari","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02095778794704758,"gpt":0.2764088675186831,"spread":0.2554510795716355,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005894813,0.0004418481,0.0006920364,0.0003424537,0.0001638772,0.00005158858,0.0003061304,0.0003456167,0.002905179],"category_scores_gemma":[0.0004352387,0.0003693855,0.0001533348,0.002192047,0.000240462,0.0002340944,0.0001721834,0.0009146763,0.001682984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004856445,"about_ca_system_score_gemma":0.0003730156,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002640875,"about_ca_topic_score_gemma":0.0007761916,"domain_scores_codex":[0.995917,0.0001966848,0.0007236379,0.0009427381,0.001226493,0.0009934069],"domain_scores_gemma":[0.9976684,0.0002423654,0.0001830314,0.001176521,0.0003668483,0.0003628521],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1052524,0.005628404,0.3515631,0.0007940116,0.001025992,0.004773187,0.00525307,0.000154778,0.06635723,0.00009054659,0.300951,0.1581563],"study_design_scores_gemma":[0.09276722,0.006853325,0.540109,0.0009814963,0.0001119209,0.0000781846,0.001543141,0.0020931,0.0257147,0.00006267607,0.3284884,0.001196871],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9692737,0.0001680804,0.000006053307,0.0004644179,0.0002628434,0.001509364,0.0001028877,0.0004292791,0.02778341],"genre_scores_gemma":[0.9491892,0.00007668828,0.0002713696,0.0001727777,0.0002093716,0.0000990573,0.001294833,0.0001615395,0.0485252],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1885459,"threshold_uncertainty_score":0.9998758,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386631797","doi":"10.1097/hs9.0000000000000953","title":"Current and Future Perspective in Hematopoietic Stem Progenitor Cell-gene Therapy for Inborn Errors of Metabolism","year":2023,"lang":"en","type":"editorial","venue":"HemaSphere","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Progenitor cell; Genetic enhancement; Stem cell; Haematopoiesis; Hematopoietic stem cell; Perspective (graphical); Bioinformatics; Cancer research; Progenitor; Biology; Gene; Medicine; Genetics; Computer science","authors":[{"name":"Francesca Tucci","is_ca":false},{"name":"Giulia Consiglieri","is_ca":false},{"name":"Matilde Cossutta","is_ca":false},{"name":"Maria Ester Bernardo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0220334038362064,"gpt":0.329828977943311,"spread":0.3077955741071046,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003966354,0.0004935841,0.001275295,0.0002240041,0.00006583708,0.00002690579,0.000261251,0.0008328488,0.00008483862],"category_scores_gemma":[0.0002735083,0.0004120922,0.0003118454,0.0006428761,0.0001420586,0.00006220256,0.0001268081,0.001106912,0.00001548977],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002836383,"about_ca_system_score_gemma":0.001053965,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001575787,"about_ca_topic_score_gemma":0.00009284901,"domain_scores_codex":[0.9967476,0.0001145726,0.0005563415,0.0008210842,0.001173712,0.0005866676],"domain_scores_gemma":[0.9976473,0.0004951041,0.0002549789,0.000495938,0.0008927676,0.0002139089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0022601,0.001010616,0.0003575379,0.006784275,0.000426616,0.0001025424,0.006778965,0.000001187186,0.001093279,0.0001503766,0.9678568,0.01317767],"study_design_scores_gemma":[0.009006632,0.0007318165,0.0002975434,0.000634799,0.0002276978,0.00000607206,0.01354127,0.00002224979,0.005498881,0.0003126561,0.9691598,0.0005606186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.06047252,0.2581141,0.00001760065,0.0007669393,0.6730637,0.006380129,0.0007212638,0.0001483042,0.0003154723],"genre_scores_gemma":[0.008474904,0.03625055,0.0006472613,0.00001840386,0.9483711,0.002269581,0.0006104522,0.0005539216,0.002803881],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.2753074,"threshold_uncertainty_score":0.9998331,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386024071","doi":"10.1097/01.hs9.0000967904.29417.23","title":"S248: SIERRA TRIAL RESULTS WITH A TARGETED RADIOTHERAPY, IOMAB-B, A MYELOABLATIVE CONDITIONING WITH REDUCED INTENSITY TOLERABILITY YIELDS HIGH CR, LONG TERM SURVIVAL IN HSCT INELIGIBLE ACTIVE R/R AML","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Fludarabine; Clinical endpoint; Hematopoietic stem cell transplantation; Population; Oncology; Transplantation; Total body irradiation; Randomized controlled trial; Gastroenterology; Surgery; Adverse effect; Chemotherapy; Cyclophosphamide","authors":[{"name":"Boglarka Gyurkocza","is_ca":false},{"name":"Stuart Seropian","is_ca":false},{"name":"Hannah Choe","is_ca":false},{"name":"Mark R. Litzow","is_ca":false},{"name":"Camille N. Abboud","is_ca":false},{"name":"Nebu Koshy","is_ca":false},{"name":"Patrick J. Stiff","is_ca":false},{"name":"Benjamin Tomlinson","is_ca":false},{"name":"Sunil Abhyankar","is_ca":false},{"name":"James M. Foran","is_ca":false},{"name":"Parameswaran Hari","is_ca":false},{"name":"George L. Chen","is_ca":false},{"name":"Zaid Al‐Kadhimi","is_ca":false},{"name":"Partow Kebriaei","is_ca":false},{"name":"Mitchell Sabloff","is_ca":true},{"name":"Johnnie J. Orozco","is_ca":false},{"name":"Katarzyna Jamieson","is_ca":false},{"name":"Margarida Silverman","is_ca":false},{"name":"Koen van Besien","is_ca":false},{"name":"Michael Schuster","is_ca":false},{"name":"Arjun Law","is_ca":true},{"name":"Sameem Abedin","is_ca":false},{"name":"Karilyn Larkin","is_ca":false},{"name":"Scott D. Rowley","is_ca":false},{"name":"Pashna N. Munshi","is_ca":false},{"name":"Rachel J. Cook","is_ca":false},{"name":"Sebastian Mayer","is_ca":false},{"name":"Moshe Levy","is_ca":false},{"name":"Hillard M. Lazarus","is_ca":false},{"name":"Brenda M. Sandmaier","is_ca":false},{"name":"Vijay Reddy","is_ca":false},{"name":"Jennifer Spross","is_ca":false},{"name":"Kathleen McNamara","is_ca":false},{"name":"Elaina Haeuber","is_ca":false},{"name":"Madhuri Vusirikala","is_ca":false},{"name":"Akash Nahar","is_ca":false},{"name":"John M. Pagel","is_ca":false},{"name":"Sergio Giralt","is_ca":false},{"name":"Avinash Desai","is_ca":false},{"name":"Rajneesh Nath","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03122284311210522,"gpt":0.3114139022138427,"spread":0.2801910591017375,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009991932,0.0005101245,0.001241201,0.0003169658,0.0002191359,0.00007537517,0.000248176,0.0003590154,0.0003508402],"category_scores_gemma":[0.0008492776,0.0003824496,0.000131671,0.002493527,0.0004756264,0.0003515877,0.0001259923,0.001343919,0.00004003427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001403903,"about_ca_system_score_gemma":0.001392393,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001706078,"about_ca_topic_score_gemma":0.001368351,"domain_scores_codex":[0.9958684,0.0003610293,0.0007187319,0.001114249,0.0009620719,0.0009755584],"domain_scores_gemma":[0.9972767,0.0005971416,0.0002901568,0.0008592434,0.0006177599,0.0003590122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8497469,0.001595748,0.06599729,0.0006592675,0.002212812,0.006374273,0.01738575,0.001026248,0.04117372,0.0002177515,0.006505055,0.007105154],"study_design_scores_gemma":[0.1951602,0.007044882,0.7456954,0.00146464,0.0001882986,0.0002725666,0.005576326,0.001836619,0.04136657,0.000165063,0.0002030425,0.001026396],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909659,0.00006328938,0.0002859533,0.002422662,0.0001979677,0.002741201,0.00008596321,0.0003667647,0.002870322],"genre_scores_gemma":[0.9945917,0.00004882049,0.001518373,0.0001804069,0.0003960871,0.0002875845,0.0005334014,0.0001072879,0.002336299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6796982,"threshold_uncertainty_score":0.9998627,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4382313481","doi":"10.1097/01.hs9.0000936256.84340.a7","title":"P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Multiple myeloma; Bone marrow; Internal medicine; CD8; Antibody; Oncology; Immunology; Immune system; Gastroenterology","authors":[{"name":"Niels W.C.J. van de Donk","is_ca":false},{"name":"Diana Cortés‐Selva","is_ca":false},{"name":"Tineke Casneuf","is_ca":false},{"name":"Deeksha Vishwamitra","is_ca":false},{"name":"Sarah Stein","is_ca":false},{"name":"Tatiana Perova","is_ca":false},{"name":"Elena Ramos","is_ca":false},{"name":"Leen van Steenbergen","is_ca":false},{"name":"Olivia Lau","is_ca":false},{"name":"C. Davis","is_ca":false},{"name":"Arnob Banerjee","is_ca":false},{"name":"Tara Stephenson","is_ca":false},{"name":"Clarissa Uhlar","is_ca":false},{"name":"Rachel Kobos","is_ca":false},{"name":"Judith D. Goldberg","is_ca":false},{"name":"Lixia Pei","is_ca":false},{"name":"Danielle Trancucci","is_ca":false},{"name":"Suzette Girgis","is_ca":false},{"name":"Shun Xin Wang Lin","is_ca":false},{"name":"Lei Wu","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Raluca Verona","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03761353571323822,"gpt":0.3264041341039097,"spread":0.2887905983906714,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001627544,0.000329895,0.0006175046,0.0003841961,0.0001042244,0.00002581015,0.0001380686,0.0001881515,0.0003628623],"category_scores_gemma":[0.0002036141,0.0002478919,0.0001364133,0.001426321,0.0001551843,0.0002453841,0.00008031372,0.0003666532,0.0002906382],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001805259,"about_ca_system_score_gemma":0.0001918269,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003661553,"about_ca_topic_score_gemma":0.0002530207,"domain_scores_codex":[0.9974112,0.0001247457,0.0005346411,0.0005384249,0.0008381842,0.0005528073],"domain_scores_gemma":[0.9983654,0.0002621375,0.0002678969,0.000563261,0.0003179476,0.0002233315],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003460286,0.001374005,0.9763292,0.0002813439,0.0002046935,0.0003346848,0.0004810259,0.00006701166,0.01339767,0.00001164585,0.0008663634,0.003192074],"study_design_scores_gemma":[0.01306331,0.001102936,0.9717628,0.0004381464,0.00006711905,0.000004410748,0.0007448841,0.001248785,0.01077875,0.0000165801,0.0005409112,0.0002313772],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945089,0.0003810368,0.00008022794,0.00005899602,0.00008649514,0.001288799,0.0001013934,0.0001231939,0.003371009],"genre_scores_gemma":[0.9951442,0.0001583266,0.001086179,0.00001789149,0.00004096903,0.00005146698,0.00116696,0.0000648959,0.00226912],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009603022,"threshold_uncertainty_score":0.9999973,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385644723","doi":"10.1097/01.hs9.0000967696.13096.54","title":"S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Discontinuation; Internal medicine; Refractory (planetary science); Adverse effect; Gastroenterology; Multiple myeloma; Surgery","authors":[{"name":"Mohamad Mohty","is_ca":false},{"name":"Michael H. Tomasson","is_ca":false},{"name":"Bertrand Arnulf","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Paula Rodríguez‐Otero","is_ca":false},{"name":"Joaquín Martínez‐López","is_ca":false},{"name":"Cyrille Touzeau","is_ca":false},{"name":"Hang Quach","is_ca":false},{"name":"Julien Depaus","is_ca":false},{"name":"Hisayuki Yokoyama","is_ca":false},{"name":"Salomon Manier","is_ca":false},{"name":"Noopur Raje","is_ca":false},{"name":"Marc S. Raab","is_ca":false},{"name":"Emma Searle","is_ca":false},{"name":"Eric Leip","is_ca":false},{"name":"Sharon T. Sullivan","is_ca":false},{"name":"Akos Czibere","is_ca":false},{"name":"Andrea Viqueira","is_ca":false},{"name":"Alexander M. Lesokhin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01863870885240338,"gpt":0.2789849677210768,"spread":0.2603462588686734,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001229397,0.000361464,0.0004439195,0.0001480263,0.0002727044,0.0001003991,0.0001059042,0.0002138954,0.000298804],"category_scores_gemma":[0.0001574018,0.0002887423,0.0001159967,0.0004003114,0.00009719472,0.0003210518,0.00005291286,0.0002144459,0.0001698088],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009150258,"about_ca_system_score_gemma":0.0001943432,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001801539,"about_ca_topic_score_gemma":0.0003896834,"domain_scores_codex":[0.9976246,0.00006556839,0.0003899776,0.0007259314,0.000626448,0.000567454],"domain_scores_gemma":[0.9984278,0.0002914088,0.0001697984,0.0004949869,0.000266274,0.0003497025],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03383932,0.003684186,0.7938976,0.001131911,0.0007827071,0.0008333362,0.001209683,0.000004657459,0.05526668,0.00009625209,0.0229723,0.08628137],"study_design_scores_gemma":[0.02859642,0.003668661,0.9494376,0.0002289034,0.0001412344,0.00001063043,0.0005482322,0.001838487,0.006166654,0.0001151666,0.008861979,0.0003860859],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946799,0.0006296995,0.0003873695,0.0003108537,0.0002405583,0.002401717,0.000516365,0.0002248069,0.0006087891],"genre_scores_gemma":[0.98351,0.0003646613,0.004667964,0.00004452811,0.0001581373,0.00020993,0.007222604,0.00008795255,0.003734201],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.15554,"threshold_uncertainty_score":0.9999565,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401745029","doi":"10.1002/hem3.130","title":"Biomarkers of outcome in patients undergoing CD19 CAR‐T therapy for large B cell lymphoma","year":2024,"lang":"en","type":"review","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"University of Toronto","keywords":"Chimeric antigen receptor; Chemoimmunotherapy; Medicine; Oncology; Refractory (planetary science); Lymphoma; Internal medicine; CD19; Disease; Immunotherapy; Antigen; Immunology; Rituximab; Cancer; Biology","authors":[{"name":"Inna Y. Gong","is_ca":true},{"name":"Daisy Tran","is_ca":true},{"name":"Samuel D. Saibil","is_ca":true},{"name":"Rob C. Laister","is_ca":true},{"name":"John Kuruvilla","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06631002535945682,"gpt":0.379980524641565,"spread":0.3136704992821082,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005888019,0.0005626128,0.002399746,0.0003354845,0.00003591604,0.00002783687,0.0002897116,0.0005236659,0.001291447],"category_scores_gemma":[0.00009673792,0.0004195338,0.001205706,0.00077009,0.00004950426,0.00004233799,0.0001230928,0.0003382926,0.0001061176],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006318236,"about_ca_system_score_gemma":0.0008078872,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004985653,"about_ca_topic_score_gemma":0.0000676795,"domain_scores_codex":[0.9968094,0.0001430995,0.001126053,0.000670303,0.0005841402,0.0006670092],"domain_scores_gemma":[0.9982049,0.0004710866,0.0002800871,0.000746145,0.0001348308,0.0001629483],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003987946,0.001322899,0.003289922,0.1296095,0.0008833665,0.00005689137,0.0001579052,5.946432e-8,0.00001747848,0.0000837355,0.004792445,0.859387],"study_design_scores_gemma":[0.009081463,0.0006797176,0.0000945026,0.01381661,0.0005371784,0.000008410572,0.00009937505,0.000008314863,0.00004747513,0.00003434288,0.9752249,0.000367748],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001678542,0.9890791,0.000009661248,0.00002444433,0.0004133862,0.00404625,0.0001991101,0.00005509227,0.004494371],"genre_scores_gemma":[0.0006320687,0.983705,0.0002170092,0.00005617644,0.0001439966,0.0003296125,0.0003515407,0.0002614646,0.01430317],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9704324,"threshold_uncertainty_score":0.9998257,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2950984087","doi":"10.1097/01.hs9.0000563784.11014.52","title":"PS1377 IMPROVEMENT IN HEALTH‐RELATED QUALITY OF LIFE FOR NEWLY DIAGNOSED MULTIPLE MYELOMA TRANSPLANT‐ELIGIBLE PATIENTS TREATED WITH DARATUMUMAB, BORTEZOMIB, THALIDOMIDE, AND DEXAMETHASONE: CASSIOPEIA STUDY","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; University of Saskatchewan; Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University; Hotel Dieu Hospital","funders":"","keywords":"Medicine; Daratumumab; Bortezomib; Multiple myeloma; Internal medicine; Autologous stem-cell transplantation; Oncology","authors":[{"name":"Murielle Roussel","is_ca":false},{"name":"Philippe Moreau","is_ca":true},{"name":"Michel Attal","is_ca":false},{"name":"Jean‐Claude Eisenmann","is_ca":false},{"name":"Kamel Laribi","is_ca":false},{"name":"Arnaud Jaccard","is_ca":false},{"name":"M. Dib","is_ca":true},{"name":"Borhane Slama","is_ca":true},{"name":"Carine Chaleteix","is_ca":true},{"name":"Véronique Dorvaux","is_ca":false},{"name":"Bruno Royer","is_ca":true},{"name":"Laurent Frenzel","is_ca":true},{"name":"Sonja Zweegman","is_ca":true},{"name":"Saskia K. Klein","is_ca":true},{"name":"Annemiek Broijl","is_ca":false},{"name":"K.‐S. Jie","is_ca":false},{"name":"C. Araujo","is_ca":true},{"name":"Véronique Vanquickelberghe","is_ca":true},{"name":"Carla de Boer","is_ca":true},{"name":"Tobias Kampfenkel","is_ca":false},{"name":"Jessica Vermeulen","is_ca":true},{"name":"C. McKay","is_ca":true},{"name":"Katharine S. Gries","is_ca":false},{"name":"Jeremiah Trudeau","is_ca":true},{"name":"Pieter Sonneveld","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03098393264413396,"gpt":0.3156171613640681,"spread":0.2846332287199341,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005844389,0.000379396,0.001225374,0.0001349283,0.00009833571,0.00002259949,0.0001121257,0.0001423336,0.0001384097],"category_scores_gemma":[0.0002643642,0.0002737035,0.0001079805,0.0003895379,0.00007404907,0.0001340358,0.00004109452,0.0002407946,0.00001088427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001852527,"about_ca_system_score_gemma":0.0003156596,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01328676,"about_ca_topic_score_gemma":0.005883516,"domain_scores_codex":[0.996729,0.000246018,0.001086329,0.0006900923,0.0005943397,0.0006542053],"domain_scores_gemma":[0.9977837,0.00059854,0.0003753782,0.0005343099,0.0002171306,0.000490948],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01433152,0.003720233,0.9709384,0.001103475,0.0004830454,0.00006453657,0.001255451,0.00001610383,0.001017409,0.000009956775,0.0000855624,0.006974268],"study_design_scores_gemma":[0.09036678,0.008446173,0.8962914,0.000428196,0.00007029693,0.000004767556,0.001447087,0.0006039013,0.002039404,0.000007318724,0.00004973854,0.0002449291],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990337,0.0005998895,0.00002175188,0.000120734,0.00004347157,0.008371559,0.0002164776,0.00004882284,0.0002403216],"genre_scores_gemma":[0.9976335,0.00008878466,0.0008580892,0.00006885573,0.00001262238,0.0004836092,0.0003019657,0.00006010552,0.0004924872],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07603525,"threshold_uncertainty_score":0.9999715,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3005555374","doi":"10.1097/01.hs9.0000563932.34778.38","title":"PS1414 A PHASE 1B/2 STUDY OF SELINEXOR, CARFILZOMIB, AND DEXAMETHASONE (SKD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont; Vancouver General Hospital; CancerCare Manitoba; Royal Victoria Hospital; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Carfilzomib; Internal medicine; Refractory (planetary science); Dexamethasone; Oncology; Phases of clinical research; Gastroenterology; Multiple myeloma; Lenalidomide; Adverse effect; Pharmacology; Chemotherapy","authors":[{"name":"Cristina Gasparetto","is_ca":false},{"name":"Suzanne Lentzsch","is_ca":false},{"name":"Gary J. Schiller","is_ca":false},{"name":"Natalie S. Callander","is_ca":false},{"name":"C. Chen","is_ca":true},{"name":"Darrell White","is_ca":true},{"name":"Rami Kotb","is_ca":true},{"name":"Heather J. Sutherland","is_ca":true},{"name":"Michaël Sébag","is_ca":true},{"name":"Sascha A. Tuchman","is_ca":false},{"name":"Muhamed Baljević","is_ca":false},{"name":"Jack W. Singer","is_ca":false},{"name":"Richard LeBlanc","is_ca":true},{"name":"Chris Venner","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":false},{"name":"Karla Rodriguez-Lopez","is_ca":false},{"name":"Heidi Sheehan","is_ca":false},{"name":"Jean-Richard Saint-Martin","is_ca":false},{"name":"Jatin J. Shah","is_ca":false},{"name":"Sharon Shacham","is_ca":false},{"name":"Michael Kauffman","is_ca":false},{"name":"Brea Lipe","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02940570002004456,"gpt":0.328572253292662,"spread":0.2991665532726175,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003133193,0.0002858086,0.0007348915,0.0001580305,0.00004347991,0.00001371692,0.0001137393,0.0001503752,0.0006747404],"category_scores_gemma":[0.0003878608,0.0002332854,0.00008535286,0.0003736217,0.00007225003,0.00009969294,0.0001135307,0.0003860798,0.0001137421],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001145935,"about_ca_system_score_gemma":0.0001489945,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00108035,"about_ca_topic_score_gemma":0.001172362,"domain_scores_codex":[0.9977725,0.0001612745,0.0005053141,0.0005530216,0.0005358947,0.0004720568],"domain_scores_gemma":[0.9984003,0.0003702491,0.0001421756,0.0006329064,0.0001389726,0.0003154459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003846123,0.01329214,0.9162573,0.0004130705,0.0003569132,0.0006340999,0.002093516,0.000008882732,0.0195078,0.00001115743,0.0002716094,0.04330744],"study_design_scores_gemma":[0.2562304,0.01582117,0.6924486,0.0007349451,0.000300903,0.0001514816,0.0126525,0.006854496,0.01123336,0.00004537081,0.002863933,0.0006628316],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994121,0.001793534,0.000007965105,0.00006961879,0.00007725014,0.002121269,0.00002735619,0.00004837052,0.001733704],"genre_scores_gemma":[0.9965364,0.00008902177,0.001201216,0.00004741146,0.00005438057,0.00009369149,0.0000319316,0.00005067005,0.001895278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2523843,"threshold_uncertainty_score":0.9513105,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385707295","doi":"10.1097/01.hs9.0000970420.62475.d0","title":"P879: LONG-TERM FOLLOW-UP FROM MAJESTEC-1 OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Multiple myeloma; Daratumumab; Cytokine release syndrome; Oncology; Bortezomib; Refractory (planetary science); Gastroenterology; Surgery; Cancer; Clinical trial; Immunotherapy; Chimeric antigen receptor","authors":[{"name":"Surbhi Sidana","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Alfred L. Garfall","is_ca":false},{"name":"Manisha Bhutani","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Ajay K. Nooka","is_ca":false},{"name":"Tom Martin","is_ca":false},{"name":"Laura Rosiñol Dachs","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Rakesh Popat","is_ca":false},{"name":"Britta Besemer","is_ca":false},{"name":"Joaquín Martínez‐López","is_ca":false},{"name":"Amrita Krishnan","is_ca":false},{"name":"Michel Delforge","is_ca":false},{"name":"Danielle Trancucci","is_ca":false},{"name":"Raluca Verona","is_ca":false},{"name":"Tara Stephenson","is_ca":false},{"name":"Katherine Chastain","is_ca":false},{"name":"Niels W.C.J. van de Donk","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01996740738613229,"gpt":0.2765928248278406,"spread":0.2566254174417083,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001449285,0.0003815315,0.0006515894,0.0002788251,0.0001041398,0.00004019947,0.0001992914,0.0002400882,0.0005978851],"category_scores_gemma":[0.0001377067,0.0003025954,0.0001558497,0.0008873714,0.0001239292,0.0002589116,0.0001118697,0.0003705325,0.0004132694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001911634,"about_ca_system_score_gemma":0.000194049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000528302,"about_ca_topic_score_gemma":0.0009489454,"domain_scores_codex":[0.9970549,0.0001050192,0.000576996,0.0006640239,0.0009453119,0.0006537634],"domain_scores_gemma":[0.9982257,0.000214465,0.0002472833,0.0007833213,0.0002445047,0.0002847094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004661703,0.001229855,0.9696454,0.0003126308,0.0001688954,0.0005770863,0.0003806129,0.000004172569,0.01402189,0.000004032561,0.0007988279,0.008194899],"study_design_scores_gemma":[0.02339902,0.0008250996,0.9647265,0.000648917,0.00005658535,0.000003374666,0.0002357242,0.0001690668,0.009324816,0.00001336163,0.0003277992,0.000269727],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960107,0.0004617136,0.00004672173,0.00006765494,0.0002394271,0.001530712,0.0002192982,0.000158603,0.001265138],"genre_scores_gemma":[0.9934517,0.0002048846,0.000739126,0.00002332419,0.00008454984,0.00006704694,0.002943887,0.00009451175,0.002390949],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01873731,"threshold_uncertainty_score":0.9999426,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4398185210","doi":"10.1002/hem3.69","title":"Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)","year":2024,"lang":"en","type":"review","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Myelodysplastic syndromes; Medicine; Drug development; Clinical trial; Drug; Intensive care medicine; Oncology; Medical physics; Internal medicine; Pharmacology; Bone marrow","authors":[{"name":"Fabio Efficace","is_ca":false},{"name":"Rena Buckstein","is_ca":true},{"name":"Gregory A. Abel","is_ca":false},{"name":"Johannes M. Giesinger","is_ca":false},{"name":"Pierre Fenaux","is_ca":false},{"name":"Jan Philipp Bewersdorf","is_ca":false},{"name":"Andrew M. Brunner","is_ca":false},{"name":"Rafael Bejar","is_ca":false},{"name":"Uma Borate","is_ca":false},{"name":"Amy E. DeZern","is_ca":false},{"name":"Peter L. Greenberg","is_ca":false},{"name":"Gail J. Roboz","is_ca":false},{"name":"Michael R. Savona","is_ca":false},{"name":"Francesco Sparano","is_ca":false},{"name":"Jacqueline Boultwood","is_ca":false},{"name":"Rami S. Komrokji","is_ca":false},{"name":"David A. Sallman","is_ca":false},{"name":"Zhuoer Xie","is_ca":false},{"name":"Guillermo Sanz","is_ca":false},{"name":"Hetty E. Carraway","is_ca":false},{"name":"Justin Taylor","is_ca":false},{"name":"Stephen D. Nimer","is_ca":false},{"name":"Matteo Giovanni Della Porta","is_ca":false},{"name":"Valeria Santini","is_ca":false},{"name":"Maximilian Stahl","is_ca":false},{"name":"Uwe Platzbecker","is_ca":false},{"name":"Mikkael A. Sekeres","is_ca":false},{"name":"Amer M. Zeidan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2713230922332107,"gpt":0.483135307900352,"spread":0.2118122156671414,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002193071,0.0007894878,0.003344181,0.0001852539,0.0001758006,0.0002468672,0.000347524,0.0005767907,0.0004958084],"category_scores_gemma":[0.01791586,0.0004482712,0.0007957525,0.0003631116,0.0002809219,0.0001680124,0.0002569642,0.001508024,0.000112684],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001027955,"about_ca_system_score_gemma":0.009329316,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002026142,"about_ca_topic_score_gemma":0.0001284059,"domain_scores_codex":[0.9927267,0.0006433475,0.003520569,0.001281927,0.001139118,0.0006883474],"domain_scores_gemma":[0.979525,0.01755855,0.001071197,0.0005942922,0.0008996862,0.000351309],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.009900771,0.005318034,0.004270745,0.07923374,0.01790131,0.00158439,0.006952188,0.00001175116,5.395605e-7,0.001183154,0.3631153,0.510528],"study_design_scores_gemma":[0.01091401,0.0007683163,0.0001668334,0.03000001,0.004991284,0.0002991939,0.001128241,0.0004976229,0.000006196016,0.000264392,0.9501804,0.0007834597],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01667483,0.907046,0.002217546,0.009769741,0.00453426,0.05233611,0.006709565,0.0003281434,0.0003837577],"genre_scores_gemma":[0.01326857,0.8522329,0.06460399,0.002610309,0.002831102,0.03909024,0.02106218,0.001097653,0.003203059],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5870651,"threshold_uncertainty_score":0.9997969,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2924768710","doi":"10.1097/hs9.0000000000000233","title":"AXL Inhibition Extinguishes Primitive JAK2 Mutated Myeloproliferative Neoplasm Progenitor Cells","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Discovery Centre","funders":"Blood Cancer UK; Medical Research Council; Bloodwise; Cancer Research UK","keywords":"Myeloproliferative neoplasm; Essential thrombocythemia; Polycythemia vera; Myeloid leukemia; Cancer research; Thrombopoietin receptor; Janus kinase 2; Myeloproliferative Disorders; Myelofibrosis; Tyrosine kinase; Stem cell; Haematopoiesis; Myeloid; Medicine; Polycythaemia; Biology; Immunology; Internal medicine; Receptor; Bone marrow; Thrombopoietin; Genetics","authors":[{"name":"Stella Pearson","is_ca":false},{"name":"Rognvald Blance","is_ca":false},{"name":"Tim C. P. Somervaille","is_ca":false},{"name":"Anthony D. Whetton","is_ca":true},{"name":"Andrew Pierce","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007214455750966063,"gpt":0.2344571461380814,"spread":0.2272426903871153,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001535938,0.0004830058,0.0007053919,0.00007982283,0.0001617744,0.0000734248,0.00006862907,0.0002352353,0.002859322],"category_scores_gemma":[0.0001094539,0.0003879749,0.0002245085,0.0003288914,0.00008973829,0.0001878704,0.00006785007,0.0003484827,0.002473193],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002699863,"about_ca_system_score_gemma":0.0003065591,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003809988,"about_ca_topic_score_gemma":0.00003891532,"domain_scores_codex":[0.9975398,0.0001159127,0.0004996391,0.0007655511,0.0005239366,0.0005551742],"domain_scores_gemma":[0.9983717,0.0002055468,0.000214274,0.0004203669,0.000484015,0.0003040936],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003317045,0.007183152,0.5788128,0.002025642,0.003024537,0.003002899,0.01595476,0.000161229,0.3210686,0.006892093,0.0269144,0.03164286],"study_design_scores_gemma":[0.00641612,0.001560698,0.03548733,0.0007089083,0.0002621984,0.0002480288,0.001631451,0.0003043574,0.9419948,0.0001866689,0.01060672,0.0005926678],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9526554,0.0003345413,0.00003644552,0.0007150294,0.0004217694,0.002757211,0.00004387188,0.0002208653,0.04281488],"genre_scores_gemma":[0.9875635,0.00007925848,0.003325955,0.000791339,0.0003976319,0.0004662508,0.0001808715,0.00008283112,0.007112353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6209263,"threshold_uncertainty_score":0.9998572,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4225775959","doi":"10.1097/hs9.0000000000000705","title":"Concurrent Composite Lymphomas Collectively Bearing Three Diagnostic Entities of Shared Clonal Origin","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Paul's Hospital; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Germinal center; Medicine; Internal medicine; Oncology; Cancer research; Pathology; B cell; Immunology; Antibody","authors":[{"name":"Waleed Alduaij","is_ca":true},{"name":"Laura K. Hilton","is_ca":true},{"name":"Muntadhar Al Moosawi","is_ca":true},{"name":"Susana Ben‐Neriah","is_ca":true},{"name":"Barbara Meissner","is_ca":true},{"name":"Merrill Boyle","is_ca":true},{"name":"Kelly Mekwunye","is_ca":true},{"name":"David W. Scott","is_ca":true},{"name":"Heather A. Leitch","is_ca":true},{"name":"Jeffrey W. Craig","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02752703303518759,"gpt":0.2662789280037343,"spread":0.2387518949685467,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007470597,0.0001922913,0.0004338854,0.00005920826,0.0002422528,0.00002024376,0.0001090889,0.00003717859,0.005055853],"category_scores_gemma":[0.00005873667,0.0001782049,0.000184774,0.0002662855,0.0000780066,0.00005381863,0.0001877751,0.0001037493,0.0000324481],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005863006,"about_ca_system_score_gemma":0.0003062158,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004543625,"about_ca_topic_score_gemma":0.00007699861,"domain_scores_codex":[0.9985707,0.00004439679,0.0003149358,0.0002995144,0.0005048956,0.0002655023],"domain_scores_gemma":[0.9990432,0.0003803679,0.0001354134,0.0002297079,0.00009007064,0.0001212152],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001698547,0.001952982,0.9723302,0.0002350613,0.0005188595,0.00042608,0.0007429828,0.0001327245,0.0009366957,0.005251314,0.01105544,0.006247783],"study_design_scores_gemma":[0.01124935,0.001511746,0.9337176,0.0003833295,0.0005578782,0.0003815371,0.0008858311,0.0005405526,0.0114849,0.0004899709,0.03840484,0.0003924398],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848619,0.004344572,0.00003581831,0.0002751832,0.0003777076,0.0006506483,0.0002258499,0.00006642252,0.009161932],"genre_scores_gemma":[0.9976857,0.0000737956,0.0003742394,0.0001324452,0.00007398078,0.0003865571,0.0001300848,0.00002657613,0.00111663],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0386126,"threshold_uncertainty_score":0.9958537,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4408845598","doi":"10.1002/hem3.70106","title":"Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: Insights from the Landmark 2.0 global health survey","year":2025,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; University of British Columbia","funders":"AOP Orphan; Astellas Pharma; Galecto; Sierra Oncology; Incyte; CTI Biopharma; BeiGene; Bristol-Myers Squibb; AstraZeneca; CSL Behring; MPN Research Foundation; Alexion Pharmaceuticals; Gilead Sciences; Sanofi; GlaxoSmithKline; Pfizer; Novartis Pharmaceuticals Corporation; Celgene","keywords":"Medicine; Depression (economics); Myeloproliferative neoplasm; Quality of life (healthcare); Polycythemia vera; Family medicine; Disease; Physical therapy; Emergency medicine; Internal medicine; Myelofibrosis","authors":[{"name":"Claire Harrison","is_ca":false},{"name":"David M. Ross","is_ca":false},{"name":"Laura Fogliatto","is_ca":false},{"name":"Lynda Foltz","is_ca":true},{"name":"Lambert Busque","is_ca":true},{"name":"Zhijian Xiao","is_ca":false},{"name":"Florian H. Heidel","is_ca":false},{"name":"Michael Koehler","is_ca":false},{"name":"Giuseppe A. Palumbo","is_ca":false},{"name":"Massimo Breccia","is_ca":false},{"name":"Norio Komatsu","is_ca":false},{"name":"Keita Kirito","is_ca":false},{"name":"Blanca Xicoy Cirici","is_ca":false},{"name":"Joaquín Martínez‐López","is_ca":false},{"name":"Alicia Rovó","is_ca":false},{"name":"Cheryl Petruk","is_ca":false},{"name":"Catalin Bobirca","is_ca":false},{"name":"Laura Mirams","is_ca":false},{"name":"Abigail McMillan","is_ca":false},{"name":"Gavin Harper","is_ca":false},{"name":"Jean‐Jacques Kiladjian","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01158140979650688,"gpt":0.3007316178053178,"spread":0.2891502080088109,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002955937,0.0001606056,0.0003469761,0.00002291406,0.0002020503,0.00002590464,0.00002225277,0.00005347223,0.00002097772],"category_scores_gemma":[0.00003141784,0.0001003096,0.00003711169,0.0001781425,0.00006174407,0.00003635172,0.0000303209,0.00006712091,0.000005625401],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002571318,"about_ca_system_score_gemma":0.000151997,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003554589,"about_ca_topic_score_gemma":0.02862161,"domain_scores_codex":[0.9990907,0.0001669566,0.000209474,0.0002882826,0.0000807819,0.0001638567],"domain_scores_gemma":[0.9993276,0.0003249229,0.00005166629,0.0001836546,0.00003315068,0.00007900317],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00008279247,0.0003132424,0.9787941,0.00001250752,0.0001622746,0.00001246047,0.003763649,0.000002034845,0.00001298552,0.00189682,0.001274133,0.01367298],"study_design_scores_gemma":[0.002129909,0.0002902659,0.9916593,0.0002164751,0.00005400907,0.00001142979,0.004514679,0.0001014244,0.00008689332,0.0003544183,0.0005078402,0.00007334928],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887763,0.005558134,0.00002691895,0.003437937,0.00006517922,0.0005265111,0.00009977931,0.00002274125,0.001486522],"genre_scores_gemma":[0.9979233,0.0005867896,0.0001997894,0.0009246793,0.00002673636,0.0001358474,0.0001369462,0.000006731915,0.00005913897],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02506702,"threshold_uncertainty_score":0.9891035,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404813541","doi":"10.1002/hem3.70001","title":"Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphoma","year":2024,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Veterinärmedizinische Universität Wien; Universität Wien; Christian Doppler Forschungsgesellschaft; Vienna Science and Technology Fund; Austrian Science Fund; Medizinische Universität Wien; European Commission; Siemens Medical Solutions USA","keywords":"Myeloid leukemia; Dual (grammatical number); Lymphoma; Block (permutation group theory); Cancer research; Acute leukemia; Leukemia; Medicine; Immunology; Mathematics","authors":[{"name":"Daniel Pölöske","is_ca":false},{"name":"Helena Sorger","is_ca":false},{"name":"Anna Schönbichler","is_ca":false},{"name":"Elvin D. de Araujo","is_ca":true},{"name":"Heidi A. Neubauer","is_ca":false},{"name":"Anna Orlova","is_ca":false},{"name":"Sanna Timonen","is_ca":false},{"name":"Diaaeldin I. Abdallah","is_ca":true},{"name":"Aleksandr Ianevski","is_ca":false},{"name":"Heikki Kuusanmäki","is_ca":false},{"name":"Marta Surbek","is_ca":false},{"name":"Elizabeth Heyes","is_ca":false},{"name":"Thomas Eder","is_ca":false},{"name":"Christina Wagner","is_ca":false},{"name":"Tobias Suske","is_ca":false},{"name":"Martin Metzelder","is_ca":false},{"name":"Michael Bergmann","is_ca":false},{"name":"Maik Dahlhoff","is_ca":false},{"name":"Florian Grebien","is_ca":false},{"name":"Roman Fleck","is_ca":false},{"name":"Christine Pirker","is_ca":false},{"name":"Walter Berger","is_ca":false},{"name":"Emir Hadzijusufovic","is_ca":false},{"name":"Wolfgang R. Sperr","is_ca":false},{"name":"Lukas Kenner","is_ca":false},{"name":"Peter Valent","is_ca":false},{"name":"Tero Aittokallio","is_ca":false},{"name":"Marco Herling","is_ca":false},{"name":"Satu Mustjoki","is_ca":false},{"name":"Patrick T. Gunning","is_ca":true},{"name":"Richard Moriggl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01169715660341519,"gpt":0.2629680298935974,"spread":0.2512708732901822,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002765403,0.0004752561,0.0005631431,0.0001806985,0.0001759364,0.0001802244,0.0001642015,0.0002796818,0.0004146622],"category_scores_gemma":[0.00004625,0.0003856845,0.00020867,0.0006614935,0.0003223789,0.0002294782,0.0002120262,0.0008233439,0.000719256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001579044,"about_ca_system_score_gemma":0.001027753,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001094954,"about_ca_topic_score_gemma":0.00001807805,"domain_scores_codex":[0.9970646,0.0001049356,0.0003567089,0.0009152048,0.0007003809,0.0008581814],"domain_scores_gemma":[0.9985071,0.0003876979,0.00005002363,0.0004894771,0.0000992352,0.0004664226],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0023974,0.0004211234,0.002655819,0.003824823,0.002097105,0.02209336,0.004521156,0.00001806194,0.1825563,0.002326244,0.5981347,0.178954],"study_design_scores_gemma":[0.02550978,0.002531753,0.05122667,0.00196546,0.001188201,0.0128474,0.005009776,0.01130786,0.1419886,0.0007571976,0.7431186,0.002548732],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9613143,0.02329409,0.00007687108,0.001583271,0.0009494402,0.0009406935,0.00002835586,0.0004637429,0.01134929],"genre_scores_gemma":[0.9583788,0.00203784,0.002119776,0.0003304026,0.0006406358,0.00006198692,0.00006455243,0.0001531813,0.03621285],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1764052,"threshold_uncertainty_score":0.9998595,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2950604500","doi":"10.1097/01.hs9.0000562556.40615.f8","title":"PS1065 OPEN‐LABEL STUDY OF GILTERITINIB, GILTERITINIB PLUS AZACITIDINE, OR AZACITIDINE ALONE IN NEWLY DIAGNOSED FLT3‐MUTATED AML PATIENTS INELIGIBLE FOR INTENSIVE CHEMOTHERAPY: RESULTS FROM THE SAFETY COHORT","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Cohort; Chemotherapy; Surgery; Internal medicine; Gastroenterology; Adverse effect","authors":[{"name":"Jordi Esteve","is_ca":false},{"name":"Rik Schots","is_ca":false},{"name":"Jeong Hoon Lee","is_ca":false},{"name":"E. Wang","is_ca":false},{"name":"Shira Dinner","is_ca":false},{"name":"Mark D. Minden","is_ca":true},{"name":"Olga Salamero","is_ca":false},{"name":"Jorge Sierra","is_ca":false},{"name":"Gabriela Yoshimoto","is_ca":false},{"name":"Kamel Laribi","is_ca":false},{"name":"Janusz Hałka","is_ca":false},{"name":"Pau Montesinos","is_ca":false},{"name":"S. Liu","is_ca":false},{"name":"Elizabeth Rich","is_ca":false},{"name":"Erkut Bahceci","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04942912092761675,"gpt":0.3420307488687258,"spread":0.292601627941109,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008589805,0.0005957421,0.001795058,0.0001228828,0.0001340088,0.00009984622,0.0009944889,0.0002841626,0.0008830403],"category_scores_gemma":[0.00229671,0.0004162451,0.0001476335,0.0009850125,0.0002207259,0.0002954663,0.000622676,0.0005192738,0.00008410071],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003428426,"about_ca_system_score_gemma":0.002969879,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01438468,"about_ca_topic_score_gemma":0.003860988,"domain_scores_codex":[0.9947118,0.0002619227,0.001792114,0.001249893,0.001029296,0.0009550298],"domain_scores_gemma":[0.9939775,0.00218311,0.0005043127,0.001659633,0.001392438,0.000282936],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4418584,0.02854323,0.3394673,0.002738101,0.00492147,0.002911489,0.03695987,0.0005647657,0.02028933,0.0001654964,0.09262355,0.02895693],"study_design_scores_gemma":[0.8305521,0.009553534,0.09938964,0.00304881,0.0003540062,0.0000964033,0.0250269,0.01158951,0.01295823,0.0001129546,0.006204846,0.00111304],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9822831,0.0001622157,0.00003655565,0.0009500248,0.0002883555,0.01318655,0.001166187,0.00008056992,0.001846405],"genre_scores_gemma":[0.9921712,0.0002452114,0.00107349,0.001478842,0.0002120933,0.0007244993,0.001512664,0.0001691597,0.002412821],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3886937,"threshold_uncertainty_score":0.9998289,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283392950","doi":"10.1097/01.hs9.0000847476.69621.cd","title":"P1152: RESULTS FROM A PHASE I PHARMACOKINETIC (PK) AND SAFETY STUDY OF TRPH-222, A NOVEL CD22-TARGETING ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (R/R NHL)","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Pharmacokinetics; Antibody-drug conjugate; Internal medicine; Cmax; Refractory (planetary science); Phases of clinical research; Gastroenterology; Lymphoma; Oncology; Antibody; Pharmacology; Toxicity; Adverse effect; Monoclonal antibody; Immunology","authors":[{"name":"Francisco J. Hernandez‐Ilizaliturri","is_ca":false},{"name":"John Kuruvilla","is_ca":true},{"name":"Beth Christian","is_ca":false},{"name":"Ian W. Flinn","is_ca":false},{"name":"Sarit Assouline","is_ca":true},{"name":"Matthew L. Ulrickson","is_ca":false},{"name":"Daniel J. Landsburg","is_ca":false},{"name":"H. Lowman","is_ca":false},{"name":"N. Levin","is_ca":false},{"name":"D. Maetzel","is_ca":false},{"name":"N. N. Viller","is_ca":false},{"name":"A. MacLaren","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0126925416239034,"gpt":0.2900373408021528,"spread":0.2773447991782494,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008402198,0.0004179331,0.0008731701,0.0002005755,0.0002007899,0.00002461063,0.0002750997,0.00008394457,0.002370265],"category_scores_gemma":[0.0001012062,0.0003774044,0.00009227057,0.0007754774,0.0001327314,0.0001398453,0.0003439179,0.0006788909,0.000007767393],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003230551,"about_ca_system_score_gemma":0.0002803144,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001927125,"about_ca_topic_score_gemma":0.0001352934,"domain_scores_codex":[0.9958989,0.0003214949,0.001003268,0.000932212,0.001246748,0.0005973951],"domain_scores_gemma":[0.9979665,0.0004502654,0.0004091435,0.0006896376,0.0002073017,0.0002771195],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1388092,0.06623413,0.2821139,0.0005365031,0.0007302428,0.0009035453,0.02466263,0.0003568779,0.4495048,0.000002606267,0.003171927,0.03297361],"study_design_scores_gemma":[0.680592,0.0194296,0.2296651,0.0007027533,0.0005127135,0.00003401615,0.02321856,0.004491675,0.02049,0.00001242934,0.01953722,0.001313944],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926269,0.0006287458,0.00001667828,0.00008173749,0.0001455757,0.002722356,0.00056025,0.00005380054,0.00316398],"genre_scores_gemma":[0.997069,0.00007361866,0.0003982096,0.0001329082,0.00008927034,0.0001039845,0.0005388419,0.0001173727,0.001476786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5417828,"threshold_uncertainty_score":0.9998678,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385667651","doi":"10.1097/01.hs9.0000971208.36694.eb","title":"P1078: MOSUNETUZUMAB DEMONSTRATES DURABLE RESPONSES IN PATIENTS WITH RELAPSED AND/OR REFRACTORY FOLLICULAR LYMPHOMA WHO HAVE RECEIVED ≥2 PRIOR THERAPIES: UPDATED ANALYSIS OF A PIVOTAL PHASE II STUDY","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; McGill University; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Follicular lymphoma; Internal medicine; Refractory (planetary science); Clinical endpoint; Phases of clinical research; Surrogate endpoint; Lymphoma; Clinical trial; Oncology; Surgery; Gastroenterology","authors":[{"name":"Laurie H. Sehn","is_ca":true},{"name":"Nancy L. Bartlett","is_ca":false},{"name":"Matthew J. Matasar","is_ca":false},{"name":"Stephen J. Schuster","is_ca":false},{"name":"Sarit Assouline","is_ca":true},{"name":"John Kuruvilla","is_ca":true},{"name":"Mazyar Shadman","is_ca":false},{"name":"Chan Y. Cheah","is_ca":false},{"name":"Keith Fay","is_ca":false},{"name":"Matthew Ku","is_ca":false},{"name":"Loretta J. Nastoupil","is_ca":false},{"name":"Michael C. Wei","is_ca":false},{"name":"Shen Yin","is_ca":false},{"name":"Iris To","is_ca":false},{"name":"Nan Hu","is_ca":false},{"name":"Juliana Min","is_ca":false},{"name":"Elicia Penuel","is_ca":false},{"name":"Anton Belousov","is_ca":false},{"name":"Alexandre Coimbra","is_ca":false},{"name":"Skander Jemaa","is_ca":false},{"name":"Brendan C. Bender","is_ca":false},{"name":"David C. Turner","is_ca":false},{"name":"Lihua E. Budde","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02169060615391659,"gpt":0.3096533414890721,"spread":0.2879627353351555,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006630454,0.0003369322,0.001075051,0.0006581812,0.0001659041,0.00003517092,0.0001682052,0.0001663289,0.00223651],"category_scores_gemma":[0.0002344414,0.0002424849,0.0001518218,0.003274766,0.0001988482,0.0001599557,0.00009885259,0.0002415894,0.000007640129],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002073257,"about_ca_system_score_gemma":0.0003711951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005454008,"about_ca_topic_score_gemma":0.001221135,"domain_scores_codex":[0.9969408,0.0003981643,0.000635825,0.0006484773,0.000859876,0.0005168404],"domain_scores_gemma":[0.998161,0.0003561858,0.0002159828,0.0007507408,0.0003162814,0.0001997987],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08006407,0.008628425,0.8345962,0.0001429038,0.006666238,0.0008177492,0.01158519,0.00006771899,0.02180601,0.000003241059,0.0006338516,0.03498837],"study_design_scores_gemma":[0.05463182,0.01962089,0.8981845,0.0003256215,0.001307713,0.000009530123,0.01731192,0.003580036,0.003602657,0.000008475543,0.0009788119,0.0004379782],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971184,0.0003423222,0.000003409164,0.0001249237,0.00001914306,0.001857741,0.00005783144,0.0001043035,0.0003719617],"genre_scores_gemma":[0.9850062,0.0001742293,0.00013759,0.0000380801,0.000015268,0.0001216635,0.0001800716,0.00007004258,0.01425683],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06358831,"threshold_uncertainty_score":0.9986756,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}